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Gelatin is a natural material that is produced by partial hydrolysis of collagen. 
Gelatin is widely used in drug delivery in the pharmaceutical field due to its 
biocompatibility and biodegradability. It has been used to prepare hydrogel, nanosphere 
and micelle as drug carriers in pharmaceutical research. Over the last few decades, 
gelatin has been applied in gene delivery and cell delivery. The objective of this thesis 
was to develop new carriers based on gelatin to explore their delivery application in the 
biomedical field. The new gelatin-based carriers include thermosensitive micellar 
complex, hydrogel crosslinked by β-cyclodextrin (β-CD) crosslinker for drug delivery, 
and gelatin-based microgel crosslinked by succinimidyl glutarate terminated 4-arm 
poly(ethylene glycol) (MW 10000) (sPEG-4A-GS(10k)) crosslinker for cell delivery. 
In the first part of the work, gelatin-based graft copolymers with 
poly(N-isopropylacrylamide) (PNIPAAm-grafted gelatin) and methoxy poly(ethylene 
glycol)-b-poly(2-(dimethylamino) ethyl methacrylate) (MPEG-PDMAEMA) 





transfer radical polymerization (ARGET ATRP). A core-shell-corona micellar complex 
self-assembled from PNIPAAm-grafted gelatin and MPEG-PDMAEMA was obtained 
to solubilize hydrophobic drugs as a thermosensitive drug delivery system.  
In the second part of this work, gelatin was crosslinked by modified β-CD 
crosslinker to prepare crosslinked gelatin hydrogel after β-CD was activated by 
1,1-Carbonyldiimidazole (CDI) to form a highly reactive β-CD crosslinker. β-CD was 
used as the crosslinking agent and host molecule for enhanced binding of anticancer 
drug methotrexate (MTX), to achieve relatively high drug loading level as well as 
control release of the hydrophobic anticancer drug. The non-cytotoxicity of the 
hydrogel indicated the suitability of this new crosslinked gelatin hydrogel for drug 
delivery.  
In the third part of the work, gelatin was crosslinked by a new poly(ethylene 
glycol) (PEG) crosslinker sPEG-4A-GS(10k). A simple preparation method of gelatin 
microgel was developed with calcium crosslinked alginate as template. The good 
mechanical stability of microgel was obtained through crosslinking gelatin core with 
sPEG-4A-GS(10k), compared with conventional alginate microcapsules. 3T3 cells 
encapsulated within the microgels remained viable over 9 days in vitro. The new 
gelatin-based microgel formulation described in this thesis has opened a way to the 
development of cell microencapsulation technology for cell delivery. 
All in all, three promising drug or cell carriers based on gelatin were 





microgel to explore their delivery applications in the biomedical field. 
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CHAPTER 1 INTRODUCTION 
1.1 Research Background 
Biomaterial is a common term in use in the modern scientific community to 
describe materials that interact with biological systems. Biomaterial as a scientific term 
has existed for about 60 years after World War II. The most widely accepted definition 
of “biomaterial” in literature is “a nonviable material used in a medical device intended 
to interact with biological systems”; this definition is attributed to Prof. D. F. Williams 
[1]. Biomaterials have been used for many applications, such as tissue regeneration[2], 
gene delivery, protein assaying, drug delivery, wound healing and so on [3-5]. 
Biomaterials have helped to enhance the quality of life over the past 60 years.  
Gelatin is a natural material that is biocompatible, biodegradable in 
physiological environments, water permeable, edible, and soluble in hot water, while 
being insoluble in cold water [6]. Gelatin is widely used in medical, pharmaceutical, 
cosmetic, food products as stabilizing, gelling, binding and thickening agent. 
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Especially, it can be used as a biomaterial for biomedical application and its 
widespread use includes further applications such as emulsifier, foaming agent, binder, 
carrier, colloidal plasma expander and matrix for implants [7, 8].  
The major advantages of gelatin are its low toxicity, biocompatibility, 
biodegradability [9], and its ability to preserve the bioactivity of therapeutic agents 
and the functions of cells to be delivered in vivo. A large number of functional groups 
in the side chain of gelatin can be modified [10, 11] and crosslinked [12, 13]. 
Chemical modification of the gelatin backbone overcomes its drawbacks. For 
example, the α-helical structure of gelatin strands melt at body temperature and the 
functionalities of gelatin are dependent on many factors such as species, breed, age, 
manner of feeding the animal. Different methods of preparing gelatin-based 
thermosensitive polymers are proposed for tissue engineering [14] and drug delivery 
[15] applications. Poly(N-isopropylacrylamide) (PNIPAAm) has been conjugated to 
chemically modified gelatin by radical polymerization or photopolymerization to 
synthesize a thermosensitive copolymer exhibiting lower critical solution temperature 
(LCST) below the normal human body temperature [16-18]. For example, these 
materials can be applied in tissue engineering to induce cell adhesion at 37 ˚C and 
detachment at low temperature. In addition, a variety of crosslinking methods to 
synthesize gelatin networks via chemical crosslinking methods (e.g., genipin, 
formaldehyde, glutaraldehyde (GTA), carbodiimide, and transglutaminase) have been 
reported [19, 20]. After modification, gelatin-based biomaterials can be used to prepare 
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drug or cell carriers such as hydrogel, microgel, microcapsule and micelle. However, 
the application of gelatin in delivery systems has not been developed sufficiently till 
now. 
1.2 Objective and Scope of Study 
The focus of this thesis work has been on the gelatin-based biomaterials. 
Gelatin was grafted with PNIPAAm using a new living polymerization method or 
crosslinked by new crosslinkers to solubilize hydrophobic drug or enhance mechanical 
stability of microgel for delivery application. The specific objectives of this study 
were:  
To synthesize thermosensitve gelatin-based biomaterials, PNIPAAm-grafted 
gelatin, and design a thermosensitive micellar complex from graft copolymer and 
block copolymer for controlled drug delivery. 
To synthesize a series of biodegradable hydrogels based on gelatin using 
β-Cyclodextrin (β-CD) as crosslinking agent and host molecule to enhance drug 
loading level for controlled drug delivery. 
To crosslink gelatin core of microgel with succinimidyl glutarate terminated 
4-arm PEG (MW 10000) (sPEG-4A-GS(10k)) crosslinker to enhance mechanical 
stability of microgel for cell delivery. 
This thesis covers the study of the new drug or cell carriers based on gelatin and 
their delivery application. Other delivery applications of gelatin-based biomaterials, 
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such as gene delivery, are not considered.  
For various parts of the study, the key is the preparation of new functional 
gelatin-based biomaterials for drug and cell delivery applications. In the following 
chapters, the preparation processes of the new drug or cell carriers are described and the 
feasibilities of their delivery applications are determined.  
1.3 Organization of the Thesis 
Encompassing the objectives outlined previously, the detailed research works 
on the gelatin-based biomaterials and their uses as delivery carriers will be reported in 
the following chapters. Hence, a better comprehension of the original work and 
contribution of this study can be achieved.  
Chapter 2: Literature review on the topics of gelatin and representative delivery 
carriers in biomedical field. Brief summary of chemical and physical properties of 
gelatin are presented, followed by an overview of micelle, hydrogel and microcapsule. 
Chapter 3: Synthesis and characterization of thermosensitive 
PNIPAAm-grafted gelatin and MPEG-PDMAEMA, and report on a thermosensitive 
micellar complex from a graft copolymer of PNIPAAm-grafted gelatin and a block 
copolymer of MPEG-PDMAEMA for controlled drug delivery. 
Chapert 4: Demonstration of the use of 1,1’-carbonyldiimidazole (CDI) 
modified β-CD as crosslinking agent and host molecule in synthesizing gelatin 
hydrogel and controlling drug release from the hydrogel. The crosslinked gelatin 
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hydrogel was fully characterized and its application in anticancer drug delivery was 
examined. 
Chapter 5: Highlight on the utilization of a new crosslinker sPEG-4A-GS(10k) 
in crosslinking gelatin-based microgel to enhance the mechanical stability of the 
microgel for cell delivery. The microgel was explored as an efficient cell carrier.  
Chapter 6: Conclusion on the work done with possible future endeavors.  
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CHAPTER 2 LITERATURE REVIEW 
2.1 Gelatin 
Gelatin is a traditional water-soluble functional protein of high interest and 
value, having the ability of forming transparent gels under specific conditions. 
Generally obtained by heat dissolution at alkaline or acidic pH and partial hydrolysis of 
collagen in animal skins, bones and tendons, gelatin presents a structure with variable 
physical properties and chemical heterogeneity due to the differences in collagen 
sources and preparation techniques [1, 2]. Figure 2.1 shows the preparative process of 
acidic and basic gelatins from collagen. Gel-forming ability makes gelatins a valuable 
material for investigating the fundamental functional properties in colloid studies. 
Tonnes of gelatin have been reported to be used annually in the food industry, 
especially in desserts, candies, bakery products, jellied meat, ice cream, and dairy 
products. The amount of gelatin used in the pharmaceutical industry is not negligible as 
far as the manufacture of pharmaceutical capsules, ointment, cosmetics, tablet coating, 
and emulsions are concerned. Gelatin is also used in photography and some specialized 
 





Figure 2.1. Preparation process for acidic and basic gelatins from collagen.  
Reprinted from Advanced Drug Delivery Reviews, Vol. 31, Yasuhiko Tabata, Yoshito Ikada, 
Protein release from gelatin matrices, 287–301, Copyright (2010), with permission from 
Elsevier. License number 2957660536273. 
2.1.1 Chemical Composition and Structure of Gelatin  
The chemical composition of gelatin is well documented through research work 
carried out by several investigators [3, 4]. Gelatin is reported to contain 18 amino acids 
linked together in a partially ordered fashion. Three groups of amino acids are 
predominant in the gelatin molecule. Glycine or alanine accounts for about one-third to 
one-half of the total amino acid residues. Glycine is the predominant N-terminal 
residue of alkali processed gelatin, whereas alanine content tends to be larger in acid 
processed gelatin. Approximately one-fourth of the amino acid residues are either 
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proline or hydroxyproline, and nearly one-fourth are basic or acidic. The absence of 
tryptophan, an “essential” amino acid and aromatic acid residue has been emphasized 
[5].  
In his investigations, Eastoe [6] demonstrated that only a few differences exist 
in the composition of placental land mammals, oxen, and pigs, except for the low value 
of isoleucine in pig skin gelatin. The whale and fish especially show striking increases 
in the hydroxyamino acid serine and threonine compared with land mammals. The 
wallaby was also found to differ from other land mammals in having increased levels of 
serine and threonine but with only a slight effect compared with the whale and the other 
classes of marine vertebrates. No significant differences in the value of N-terminal 
residues as well as in the amino acid composition have been mentioned relating to the 
origin of gelatin. However, an overall difference in amino acid sequence with respect to 
the ends of the polypeptide chains resulting from a shift in the side of bond breaking 
remains a plausible fact. 
Chemical composition studies have revealed the presence of about 1% of sugar 
in gelatin. The type, nature, and amount of sugars vary with different authors, 
depending on the source of the gelatin and the method of determination. The sugars are 
assumed to arise from a cementing substance known as mucopolysaccharides and can 
be present in the form of amino-sugars. The mucopolysaccharides are ascribed to 
playing the role of cementing substances in the gelation and other chemical activities. 
Since 1940, gelatin structure has attached much research interest. Several 
models were established to explain the relationship in gelatin structure and its 
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properties. In brief, there are two main models, the single-chain model and the 
multichain model. In the single-chain model, the sequences of the type 
gly-pro-hypro-gly or gly-pro-hypro-gly-prohypro-gly have broad confirmation [7]. The 
multichain model consists of polypeptide chains that may be bonded together by 
crosslinks of various kinds, which gives a satisfactory interpretation of the conversion 
of collagen to a linear structured gelatin through breakage of crosslinks between 
polypeptide chains. This model provides the possibility that collagen may consist of a 
long single polypeptide chain, coiled in a random fashion and linked to itself. Therefore, 
gelatin may be obtained through breakage of the polypeptide chain and crosslinkages. 
So far, it is well accepted that gelatin presents the structure of a linear chain with very 
little ramifications. The linear chain is characterized by a chemical heterogeneity and 
some dynamic properties that depend on the preparation procedure involving different 
phenomena, such as rupture of peptide chains, breakdown or disorganization of lateral 
bonds between chains, modification of the gelatin chain configuration, etc.   
However, recent advances in gelatin studies have provided interesting insight 
into the structure of gelatin through new techniques such as laser light scattering and 
nuclear magnetic resonance and set basic data for elucidating the mechanism of gelatin 
interaction with other compounds.  
2.1.2 Physical Properties of Gelatin 
Type A gelatin has been reported to have an isoionic point of 7 to 9, and the 
isoionic point for lime (alkali) processed gelatin falls in the range of 4.8 to 5.1. The 
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dispersion and gelation, intimately related to the isoionic point, are the most important 
properties determining the use of gelatin, especially in the food industry.  
Gelatin is a water-soluble protein. However, adequate care must be taken to 
effect its dispersion. The dissolution of gelatin can be achieved through a preliminary 
soaking of the granules for a short time in adequate amounts of cold water followed 
either by heating or stirring and addition of hot water to the hydrated gelatin to reach a 
final temperature of at least 35 ˚C. The viscosity of gelatin varies widely with the type 
of gelatin, the concentration, temperature, and time. In general, acid-processed gelatin 
appears to have a slightly greater intrinsic viscosity than alkali-prepared gelatin, but no 
apparent difference has been found for melting points of gels. Gelation of gelatin may 
involve several mechanisms, which are up to now not well elucidated. It is theorized 
that small sections of a number of gelatin molecules unite to form crystallites, offering a 
structure of a highly ramified three-dimensional network capable of immobilizing the 
liquid. The fluid sol is then converted into an elastic “solid” or gel. The implication is 
that hydrogen bonds, peptide linkage and van der Waals forces in the binding of gelatin 
molecules form a fragile architecture of the gel. Gelatin is one of the rare proteins 
known to have good foaming properties. Gelatin sols cooled to 10 ˚C to reach the 
consistency of thick egg white can be whipped to yield foams at least double the 
volume of the initial sols. The effectiveness of moisture impermeable edible films, 
moisture content water activity and moisture barrier properties of edible films and 
coatings seem to be the future focus of research in gelatin.  
Gelatin is a kind of protein that contributes to an increase in the viscosity of the 
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continuous phase of an emulsion, causes delay in flocculation and coalescence, and 
enhances the stability of oil-in-water emulsions. However, gelatin by nature has poor 
emulsifying properties. Unfortunately, none of the methods employed to improve the 
functional properties of ingredient proteins has been reported to give a satisfactory 
result in improving the emulsifying properties of proteins. The availability of a method 
to improve this functionality therefore would be useful to ensure the use of gelatin for 
multifunctional purposes in food and pharmaceutical systems [3]. 
2.2 Micelle, Hydrogel and Microcapsule as Carriers for Delivery 
Application 
2.2.1 Micelle 
Micelles are colloidal particles that belong to a family of dispersed systems 
consisting of the dispersed phase or particulate matter which was distributed within a 
medium or a continuous phase [8]. For example, Figure 2.2 shows the principal 
scheme of micelle formation from an amphiphilic molecule in an aqueous medium. In 
terms of size, colloidal particles occupy a position between molecular and coarse 
dispersions. Normally, micelles have particle size within a range of 5 to 100 nm. 
Micelles belong to association colloids which is one of the three groups of colloidal 
dispersions normally divided into three principal groups — lyophilic, lyophobic and 
association colloids. Micelles consist of surfactants or amphiphilic molecules which 
have a combination of hydrophilic property and a hydrophobic property. Under certain 
conditions micelles are spontaneously formed by molecules that consist of two distinct 
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regions with opposite affinities towards a given solvent [9]. These amphiphilic 
molecules at low concentrations exist separately in the liquid phase; aggregation takes 
place within a concentration range when the concentration is increased above critical 
micelle concentration (CMC). While micelles are often pictured as spheres, it is critical 
to recognize that the micelles are not always spherical and not solid particles. The 
aggregates inclusive of amphiphilic molecules are close to spherical in shape. 
 
Figure 2.2. The general scheme of micelle formation from amphiphilic molecules.  
Reprinted from Journal of Controlled Release, Vol. 73, Vladimir P. Torchilin, Structure and 
design of polymeric surfactant-based drug delivery systems, 137–172, Copyright (2001), with 
permission from Elsevier. License number 2957941417999. 
CMC is defined as the minimum concentration of amphiphilic molecules which 
is required for micelles to form [10], while the aggregation number of micelle was 
called the number of molecules forming a micelle. CMC value for a given amphiphilic 
molecule is the most important parameter describing the micellization process. It can be 
determined using several existing methods. Although many physical parameters can be 
used to recognize the change in the system properties near CMC, several methods are 
used to determine CMC values due to their high sensitivity. Three methods, such as 
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HPLC, particle size measurement and fluorescent spectroscopy, are widely applied in 
the determination of CMC value. Among the three methods, the most precise and 
sensitive method is fluorescent spectroscopy [11]. Some fluorescent probes, such as 
pyrene, have a tendency to enter into the cores of micelles rather than in water phase 
and their fluorescence intensity changes depending on the surroundings of fluorescent 
probes [12]. The fluorescent probe is solubilized in water to a small extent at low 
concentration of amphiphilic molecules. Increasing amphiphilic molecule 
concentrations leads to the formation of the hydrophobic core of micelle which can 
solubilize fluorescent probe. The increase of fluorescence intensity is observed while 
the micelles begin to appear in the solution with increasing concentration of the 
amphiphilic molecule. Above CMC, the fluorescent probe becomes associated with the 
micelle core [13]. 
A typical curve of the increase in pyrene fluorescence intensity with increasing 
concentration of the amphiphilic molecules was shown (Figure 2.3), which 
demonstrates the calculation method for determining CMC value [14]. 
Another important parameter is a Critical Micellization Temperature or CMT. 
Below this temperature amphiphilic polymers exist as unimers, while above it both 
unimers and aggregates (micelles) are present in the system. The same methods that are 
used to find a CMC value may be successfully applied to determine CMT. The analysis 
of CMC and CMT values, as well as their dependencies on temperature and 
concentration, correspondingly, provide a simple method to determine thermodynamic 
parameters of micelle formation, such as free energy and enthalpy of micellization. 
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                                       (b) 
Figure 2.3. Fluorescence spectra of pyrene (6.0×10-7 M) against CN concentration in distilled 
water (emission wavelength: 390 nm) (a) and plots of the intensity ratio I338/I334 from pyrene 
excitation spectra vs. log C of the CN in distilled water (b).  
Reprinted from International Journal of Pharmaceutics, Vol. 205, In-Sook Kim, Young-Il Jeong, 
Chong-Su Cho, Sung-Ho Kim, Thermo-responsive self-assembled polymeric micelles for drug 
delivery in vitro, 165–172, Copyright (2000), with permission from Elsevier. License number 
2957960576057. 
The solubility of low-solubility substances can be increased by the micelle. The 
solubilization phenomenon can be significantly applied in many industries [15, 16]. In 
pharmaceutical application, water distribution is not isotropic within the structure of 
micelles made of nonionic surfactants. Water concentration near the surface is more 
than that in the core of the micelle. Due to this anisotropy, a polarity gradient from the 
hydrophilic surface to the hydrophobic core appears in such micelles. Thus, the 
distribution of solubilized drugs in the micelle depends on the polarity of the micelle. In 
water, hydrophobic drugs will be solubilized in the micelle core and hydrophilic drugs 
will be adsorbed on the surface of the micelle.  
The solubilization capacity of amphiphilic molecules for hydrophobic drugs 
depends on various factors, such as polarity of hydrophobic drug, structure of chemical 
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compound in the system, pH, etc. The solubilization is considered as a normal 
partitioning of the drug between micellar phase and aqueous phase in thermodynamics. 
The standard free energy of solubilization (∆Gୱ୭) can be expressed:  
 ∆Gୱ୭ ൌ െRT ln K                                                    (2.1) 
where R is the universal gas constant, T is the temperature in Kelvin and K is 
the corresponding partition coefficient. In general, surfactants are widely applied to 
control the properties of drug dosage forms, such as wetting, stability, bioavailability, 
etc. in pharmaceutical biotechnology [8]. Lyophilic colloids are thermodynamically 
more stable towards both dissociation and aggregation under certain conditions.  
Self-assembling delivery carriers should spontaneously form from amphiphilic 
molecules and drug [17] as they are stable in vitro and in vivo and should provoke no 
biological reactions; drugs can be released upon contact with target tissues; and after 
drugs are released, the carrier should be easily removed from human body. 
2.2.1.1 Polymeric Micelle 
Polymeric micelles, a separate class of micelles, self-assemble from 
amphiphilic copolymers which consist of hydrophilic and hydrophobic monomer units. 
There are several possible classifications of polymers, such as homopolymer, random 
copolymer, block copolymer including diblock copolymer and triblock copolymer and 
graft copolymer. Two kinds of monomeric units with different solubilities are necessary 
for the self assembly of micelles. Polymeric micelles consist of a core and shell 
structure; the hydrophobic core can encapsulate drugs with low water solubility, 
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whereas the hydrophilic outer shell or corona protects the drug from the surroundings 
and stabilizes the polymeric micelles in the human body [18].  
The hydrophobic cores of polymeric micelles are not only made up of 
hydrophobic segments of copolymer but also hydrophobic drugs through the 
conjugation of the drugs to hydrophilic copolymer [19, 20]. In addition, the core can be 
composed of polyion complex, the complexation of the two oppositely charged 
polyions [21].  
Block copolymer for polyion complex consists of two parts, charged segment 
and neutral segment, which are totally water soluble [22]. The hydrophobic core in 
polyion complex micelles is formed through the electrostatic interaction between the 
ionic segment and the charged surfactant groups. The nonionic water-soluble 
segements of the polymer, such as PEG, stabilizes the hydrophobic core of micelle 
encapsulating drugs [23]. 
Polymeric micelles have several advantages. Micelles can target tumors by a 
passive targeting mechanism called the enhanced permeability and retention (EPR) 
effect. Polymeric micelles can possess biodegradability, ideal particle size, high loading 
efficiency and accumulation in the target sites in the human body [24]. Although 
polymeric micelles without surface ligands can be internalized into cells via fluid-state 
endocytosis after accumulating in the target sites [25], the active targeting is very 
important. Polymeric micelles can be modified by ligand coupling to meet the 
requirements of active targeting. For example, transferrin, folate residues, and peptides 
were attached to micelles for active targeting [26].  
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Hydrophobic drugs result in many serious problems in therapeutic applications 
[27, 28]. A lot of drugs are not very water soluble, such as anticancer drugs. It is a 
commonly used method to solubilize the hydrophobic drug by polymeric micelles [29]. 
However, hydrophobic property is important for cell internalization. Drug with enough 
hydrophobicity can penetrate a cell membrane and has a high affinity toward target 
receptor [30].  
In polymeric micelles, drugs are entrapped in the core consisting of 
hydrophobic block copolymer and the shell consisting of hydrophilic block copolymer 
thus reducing the interactions of drugs with the surroundings. In addition, the 
polymeric micelles can be stabilized by hydrophilic shell and their opsonization is also 
prevented by the hydrophilic corona [31]. Amphiphilic diblock copolymers, triblock 
copolymers, and graft copolymers are mainly used for the preparation of polymeric 
micelles. Selecting an appropriate polymer depends on the critical purposes of 
achieving the proper drug delivery property of the micelles. Polyethers like PEG and 
poly(ethylene oxide) (PEO) are widely used for hydrophilic shells of polymeric 
micelles. Other polymers, such as poly(trimethylene carbonate) and 
poly(vinylpyrrolidone) can also be applied to the hydrophilic shells of polymeric 
micelles [32, 33]. There are multicomponent shells made up of different copolymers, 
such as PEO and polyelectrolyte [34]. The important property of the shells is to prevent 
uptake by the RES, which is for sustained release in vivo.  
The hydrophobic core is consisting of Pluronics, polyesters and poly(L-amino 
acid). poly(L-glutamate) and poly(L-aspartate) are the commonly used poly(L-amino 
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acids). Poly(ɛ-caprolactone), poly(D,L-lactic acid), and poly(glycolic acid) are the 
most commonly used polyesters. Pluronics (or poloxamers) as triblock copolymers are 
poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) type of block 
copolymers. The CMC values are influenced by the length of PPO segment [35]. By 
engineering the PEG and PPG segments, the drug delivery system can control the 
pharmacological action of the drug and targeted drug delivery is carried out [36]. There 
are several tailoring methods of the polymeric micelles. For example, the core or shell 
of the micelles is crosslinked and the surface of the micelles is functionalized [37, 38].  
Preparation of polymeric micelles includes two steps: the synthesis of the 
amphiphilic block copolymer and formation of polymeric micelles above CMC values 
using several techniques. 
Amphiphilic copolymers include diblock copolymer, triblock copolymer and 
graft copolymer. Triblock copolymer involves two types of polymers (ABA) or three 
types of polymers (ABC). Graft copolylmers are synthesized by grafting hydrophobic 
segments over the hydrophilic backbone and diblock copolymers are formed by 
coupling hydrophilic and hydrophobic blocks of polymers. The functionalities of 
polymers, such as thermosensitivity, pH sensitivity, can be achieved by coupling 
different types of polymers [39-42]. The length ratio of hydrophilic and hydrophobic 
blocks affects the conformation of copolymers in water. The amphiphilic block 
copolymer containing more than 50% hydrophilic remains monomeric in water [18]. 
The synthsis methods of amphiphilic copolymer for polymeric micelles involve solvent 
polymerization ring opening polymerization, free-radical polymerization modified 
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nanoprecipitation method, step condensation.  
After the synthesis of amphiphilic polymers, micelles can be formed by 
self-assembly of the polymers in biphasic systems followed by purification. There are 
several typical techniques which can be used in drug loading. The dialysis method 
involves several steps. A small amount of water is added to the solution of amphiphilic 
polymer solution in a water-miscible organic solvent. The mixed solution was dialyzed 
against water for a long time to remove organic solvent [43, 44]. The dialysis method is 
widely used to load hydrophobic drugs into micelles. Another method is oil-in-water 
emulsion solvent evaporation method. The amphiphilic polymer is dissolved in a 
water-immiscible organic solvent [45-47]. Then, an emulsion with continuous aqueous 
phase and an organic phase is formed by adding the solution to the distilled water. The 
diphase system rearranges the polymer to form micelles. Surfactants are applied in the 
system. All organic solvent was removed by evaporation. The third method is solid 
dispersion method. In this method, after the solution of amphiphilic polymer is 
prepared, polymer matrix is obtained after the solvent is evaporated under reduced 
pressure. Then, polymeric micelles are obtained after water is added [48, 49]. The 
fourth method is microphase separation method. In this method, the amphiphilic 
polymer is dissolved in organic solvent. Polymeric micelles are formed by adding the 
solution to water dropwise. Organic solvent is removed and polymeric micelles are 
formed. 
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2.2.1.2 Polymeric Micelle for Drug Delivery  
The solubilization of hydrophobic drugs by micelle of amphiphilic copolymer 
has attracted attention in recent years as both a theoretical and practical problem. The 
solubilization process depends on the interactions between hydrophobic blocks of the 
polymer and the solubilized drugs. In aqueous solutions, polar molecules will be 
adsorbed on the micelle surface and nonpolar molecules will be solubilized in the 
micelle core (Figure 2.4) [8]. In practice, various techniques may be used. Physical 
entrapment and chemical conjugation are used to load drug into micelle [50-53].  
 
Figure 2.4. Possible patterns of drug association with a micelle depending on the drug 
hydrophobicity (black color on a ‘drug molecule’ shows the hydrophobic area, white, the 
hydrophilic area). Completely water-soluble hydrophilic drug can only be adsorbed within the 
micelle corona compartment (case 1); while completely insoluble hydrophobic molecule can 
only be incorporated in the micelle core compartment (case 5). Drug molecules with 
intermediate hydrophobic/hydrophilic ratio will have intermediate positions within the micelle 
particle (case 2 to 4).  
Reprinted from Journal of Controlled Release, Vol. 73, Vladimir P. Torchilin, Structure and 
design of polymeric surfactant-based drug delivery systems, 137 –172, Copyright (2001), with 
permission from Elsevier. License number 2957941417999. 
 




Figure 2.5. Main structural types of copolymers.  
Reprinted from Journal of Controlled Release, Vol. 73, Vladimir P. Torchilin, Structure and 
design of polymeric surfactant-based drug delivery systems, 137 –172, Copyright (2001), with 
permission from Elsevier. License number 2957941417999. 
It is very important to select proper hydrophobic segments of the copolymer to 
enhance loading efficiency. A very simple classification of polymers and copolymers is 
presented in Figure 2.5. If AB-type block copolymers are used, the formation of 
micelles depends on the interchain cohesive interactions of one segment in a solvent. 
The cohesive interactions involve hydrophobic, electrostatic, hydrogen bonding and so 
on. It is hydrophobic interaction by which hydrophobic drugs are encapsulated in 
micelles [54]. The crosslinked core of polymeric micelles can stabilize the micelle 
morphology and influence the drug release [55]. The charged block copolymers can 
form polyion complex micelles with electrical interaction. For example, 
PEG-b-poly(α,β-aspartic acid) and PEG-b-poly(L-lysine) can form polyion complex 
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micelles [56].  
Drug release processes depend on the type of drug encapsulation. Drugs are 
released by degradation of polymer matrix or erosion while drugs are conjugated to 
polymer. If drugs were encapsulated physically, drugs are released by diffusion. In 
addition, drug loading efficiency, the length of polymer block that form the core and the 
crosslinking of the core also affect the drug release rate of the micelle [57]. Shell 
crosslinking also influences the drug release except core crosslinking [58, 59]. The 
interactions between micelle/drug formulations and protein may influence the rate of 
drug release. For example, the binding of proteins to micelles can enhance the rate of 
drug release.[60]. 
Surface modification is also important in drug delivery. Polymeric micelles 
without surface modification accumulate in the target tissue and release drugs 
spontaneously. Surface-modified polymeric micelles accumulate in the specific site and 
polymeric micelles undergo endocytosis to release drugs inside cells. Folate 
receptor-folic acid and transferring receptor-transferrin belong to receptor-ligand pairs 
following receptor mediated [61-63]. 
Biodegradable and biocompatible amphiphilic copolymers do not induce any 
incompatible reaction with the body. However, polymeric micelles should not be 
removed before they first accumulate at the target site and release drugs. Molecular 
weight is important in excretion of amphiphilic polymer for micelles. They should be in 
the range from 42 kDa to 70 kDa [64, 65]. 
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2.2.1.3 Mixed Micelle and Micellar Complex 
The application of polymeric micelles prepared from a single component is 
limited due to the limited number of functional blocks of copolymer. Two or more 
block copolymers are combined to prepare mixed micelles. The interactions of different 
copolymers in mixed micelles are classified into weak hydrophobic interactions, 
stereocomplexation, H-bonding, ionic interactions and chemical crosslinking (Figure 
2.6).  
Mixed micelles have some advantages over single-component micelles. For 
example, mixed micelles can lower CMC values and enhance drug loading efficiency 
[66-69]. This novel method can meet the requirements for clinical trial in spite of 
complicated polymer synthesis [70-72]. A model for the comicellization was proposed 
to describe the relationship between the comicellization and the concentration ratio of 
two components [73]. The CMC values of mixed micelles was derived from the CMC 
values of the components [8]. 
 




Figure 2.6. Schematic presentation of the formation of mixed micelles through various core 
interactions. (a) Hydrogen bonding, stereocomplexation or ionic interaction; (b) Hydrophobic 
interactions; and (c) Chemical crosslinking (e.g. disulfide bond). 
Reprinted from Current Opinion in Colloid & Interface Science, Vol. 16, Amalina Bte Ebrahim 
Attia, Zhan Yuin Ong, James L. Hedrick, Phin Peng Lee, Pui Lai Rachel Ee, Paula T. Hammond, 
Yi-Yan Yang, Mixed micelles self-assembled from block copolymers for drug delivery, 
182-194, Copyright (2011), with permission from Elsevier. License number 2958520839402. 
Mixed micelles provide researchers with a lot of opportunities to enhance the 
stability of micelles and design multifunctional micellar formulation. For example, the 
formation of mixed micelles allows researchers to utilize more biofriendly and 
functional polymers to optimize micelles for in vivo drug delivery applications [74]. 
Therefore, rational selections of copolymer components of mixed micelles can 
optimize the properties of conventional polymeric micelles for drug delivery 
application.  
 
Chapter 2 Literature Review  
27 
 
The micellization of block copolymers in block-selective solvents gives rise to 
core–shell micelles, where the soluble block forms the shell and the insoluble block 
forms the core. In addition to core–shell micelles, another type of micelles such as 
core-shell-corona (CSC) and ‘onion-type’ micelles have also been studied. In general, 
amphiphilic ABC triblock copolymers can be used to prepare CSC micelles [75]. For 
example, a triblock copolymer of polystyrene-block-poly(2-vinyl pyridine)- 
block-poly(ethylene oxide) (PS-b-P2VP-b-PEO) was used to prepare CSC micelles [76, 
77]. These core-shell-corona micelles provide an innovative method and may also 
influence general concepts about the self organization of polymers and the polymer 
stabilization of colloids. Compared with core–shell micelles, there is little research on 
CSC micelles, which is due to the difficulty in the synthesis of triblock copolymers and 
their complicated structure. In addition to triblock copolymers, a facile method to 
prepare CSC micelles from two different diblock copolymers AB and BC was 
suggested [78]. In this method, the AB block copolymer forms the inner core of the 
micelles, the B blocks of AB and BC block copolymers form a shell layer and the block 
C remains soluble to form the corona of the micelle.  
Another method to prepare CSC micellar complex is complexation between a 
linear polymer and core-shell micelles. For example, multilayer nanoparticles can be 
prepared by complexation between a linear polyanion of poly(sodium methacrylate) 
(PMANa) and block ionomer micelles of 
polystyrene-block-poly(N-ethyl-4-vinylpyridinium bromide) (PS-b-PEVP) [79]. The 
complexation between polystyrene-blockpoly(acrylic acid) (PS-b-PAA) micelles and 
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poly(ethylene glycol)-block-poly(4-vinyl pyridine) (PEG-b-P4VP) was utilized to 
prepare CSC micellar complexes (Figure 2.7) [80, 81]. 
 
Figure 2.7. The possible mechanism of absorption of PEG-b-P4VP into the spherical core–shell 
PS-b-PAA micelles and formation of the CSC micellar complexes.  
Reprinted from Macromol. Chem. Phys., Vol 206, Wangqing Zhang, Linqi Shi, Lichao Gao, 
Yingli An, Kai Wu, Formation of Core-Shell-Corona Micellar Complexes through Adsorption 
of Double Hydrophilic Diblock Copolymers into Core-Shell Micelles, 1341-1345, Copyright 
(2005), with permission from WILEY. License number 2958511048666. 
2.2.2 Hydrogel 
Hydrogels are three-dimensional polymeric networks capable of absorbing 
large amounts of biological fluids or water [82]. The networks contain hydrophilic 
groups or domains hydrated in aqueous solution and create the three dimensional 
hydrogel structure. Physical crosslinks or chemical crosslinks are present to make the 
hydrogel insoluble [83-86]. The crosslinks of hydrogel provide its physical integrity 
and network structure. These hydrogels are thermodynamically compatible with water, 
which allows hydrogels to swell in aqueous solution. Hydrogel can be used in many 
fields, such as medicine and pharmaceutical industry [87, 88]. Hydrogels can resemble 
natural living tissue because of their soft consistency and high water contents similar to 
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natural tissue. The high water content of hydrogel gives its biocompatibility. Hydrogels 
have been used as drug delivery devices, contact lenses, materials for artificial skin and 
linings for artificial hearts [89]. Hydrogels are classified as neutral hydrogel or ionic 
hydrogel based on the side groups. Based on the structure and mechanical property of 
hydrogel, hydrogel networks can be classified as affine networks or phantom networks. 
According to the method of preparation, hydrogels can be classified as homopolymer or 
copolymer networks. Additionally, hydrogels can be semicrystalline, amorphous and 
hydrogen-bonded, supramolecular structures and hydrocolloidal aggregates based on 
their physical structure [90]. 
The swelling property of hydrogel is very important in its biomedical 
application. Crosslinking ratio, one of the most important factors, influences the 
swelling degree of hydrogels. Crosslinking ratio is defined as the molar ratio of 
crosslinking agent to polymer repeating units [82]. The higher crosslinking ratio results 
in a tighter structure of crosslinked hydrogel and low swelling degree because the 
mobility of the polymer chain is hindered by crosslinking. The polymer chemical 
structure may also influence the swelling property of the hydrogels. More hydrophilic 
groups of hydrogels lead to a higher swelling degree of the hydrogels. The hydrogels 
containing more hydrophobic groups will swell less in water compared to hydrogels 
containing less hydrophobic groups. Swelling of stimuli-responsive hydrogel is 
affected by specific stimuli. For example, changes in temperature affect the swelling of 
temperature-responsive hydrogel and the swelling of pH-sensitive hydrogel is affected 
by pH values. The swelling kinetics of hydrogels is relaxation-controlled (non-Fickian) 
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and diffusion-controlled (Fickian) swelling. The swelling kinetics of hydrogel is 
diffusion-controlled while the diffusion rate of water into the hydrogel is much faster 
than the relaxation rate of the polymer chains [91].  
The mechanical property of hydrogel is another important property for 
biomedical applications. For instance, the integrity of undegradable drug carrier is very 
important to obtain FDA approval. A drug delivery system for the protection of protein 
must maintain its integrity to protect protein before it is released out of the drug 
delivery system. The mechanical property of the hydrogel is directly correlated with 
crosslinking degree. The higher crosslinking degree results in a stronger hydrogel. A 
brittle structure of hydrogel results from a higher degree of crosslinking. Hence, the 
crosslinking degree should be optimized to achieve optimal properties of the hydrogel. 
Cell viability assay can be used to evaluate the cytotoxicity of hydrogels. Three 
common methods to evaluate the cytotoxicity of hydrogels include agar diffusion, 
direct contact and extract dilution. The unreacted monomers, oligomers and initiators 
may cause problems with the cytotoxicity of the hydrogels. The relationship between 
the cytotoxicity of hydrogels and chemical structure has been studied extensively [92]. 
The cytotoxicity of hydrogels can be lowered by extensively washing of the polymer 
products and modifying the kinetics of polymerization to enhance monomer conversion, 
and extensive washing of the resulting hydrogel. 
2.2.2.1 Chemically Crosslinked Hydrogel 
As mentioned above, crosslinking is necessary to prevent the dissolution of the 
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hydrophilic polymer chains in an aqueous media. In physically crosslinked hydrogels, 
physical interactions existing between different polymer chains can prevent dissolution 
of hydrophilic polymer chain. In chemically crosslinked hydrogels, there are covalent 
bonds between different polymer chains. Since biodegradable hydrogels have many 
advantages, biodegradable bonds are introduced into the hydrogels. These bonds are 
present either at the crosslinking points or the polymer backbone. The biodegradable 
bonds can be hydrolyzed under physiological conditions either chemically or 
enzymatically [93]. Chemically crosslinked hydrogels can be prepared by radical 
polymerization of monomers in the presence of crosslinkers [94, 95]. The swelling 
property of hydrogel is modulated by adding amounts of crosslinker. After 
water-soluble polymers were modified with polymerizable groups, chemically 
crosslinked hydrogels were prepared by polymerization of derivatized polymer (natural, 
semi-synthetic, synthetic) [96, 97]. Enzymatical degradable hydrogels can be 
synthesized by radical polymerization. In addition, chemically degradable hydrogels 
were synthesized by connecting the water-soluble polymer and polymerizable group 
via biodegradable structures [98-102]. 
The functional groups (OH, COOH, NH2) of water-soluble polymers can also 
be used for the preparation of hydrogels. Functional groups with complementary 
reactivity can react with the functional groups of polymers. Water-soluble polymers 
with hydroxyl groups (e.g. poly(vinyl alcohol)) were crosslinked by GTA under rather 
drastic conditions while polymers with amines can be crosslinked by GTA under mild 
conditions [103-106]. Polyaldehydes obtained by oxidation of dextran, as a 
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non-cytotoxic crossliner, has been reported to crosslink the hydrogels which were used 
for wound healing [107]. The biocompatibility of hydrogels crosslinked by dextran 
dialdehyde was assayed both in vitro and in vivo. The results showed that the hydrogels 
were non-cytotoxic [108]. The swelling and degradation of the hydrogels could also be 
controlled by the amount of crosslinkers, such as adipic acid dihydrazide [109]. In 
crosslinked hydrogel, drug can be conjugated to polymer matrix and drug was released 
because of hydrolysis of the cleavable conjugation linkage [110].  
Bis (or higher) functional crosslinkers can crosslink the functional groups of 
water-soluble polymers via addition reactions. For example, 1,6-hexanedibromide, 
divinylsulfone, 1,6-hexamethylenediisocyanate can crosslink polysaccharides 
[111-113]. The properties of hydrogels can be controlled by the polymer concentration 
and the amount of crosslinker. Organic solvents were used as reaction media for 
crosslinking reactions because crosslinkers reacted with water. This results in the 
loading of pharmaceutically active agents after the preparation of hydrogels. The 
loading method leads to a limited duration of release. A degradable hydrogel in which 
PEG-dithiol was reacted with PEG-acrylates was carried out in water.  
Condensation reactions were carried out between carboxylic acids and hydroxyl 
groups or amines for the synthesis of polymer hydrogel. 
N,N-(3-dimethylaminopropyl)-N-ethyl carbodiimide (EDC) is a very efficient 
crossliner. For example, it was used to crosslink gelatin hydrogels using EDC [114]. 
N-hydroxysuccinimide (NHS) is added to reduce side reactions and to control the 
crosslinking degree of the hydrogels efficiently. The hydrogels can be used as a carrier 
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for protein release. A negatively charged polysaccharide in the hydrogel network can 
improve the loading efficiency [115]. The mechanical properties of hydrogels could be 
controlled by the molecular weight of PEG and the amount of PEG-diamine in the 
hdyrogel while alginate and PEG-diamines were crosslinked by EDC [116]. 
Water-soluble polymers derivatized with vinyl groups can be polymerized using 
high energy radiation by electron beam and particularly gamma rays [117]. A 
monofunctional acrylate can be crosslinked by a crosslinker via radiation-induced 
polymerization [118]. On the other hand, water-soluble polymers without vinyl groups 
can also be polymerized by high energy irradiation. For example, hydroxyl groups were 
generated by radiolysis of water molecules and polymer chains were attacked by the 
hydroxyl groups to form macroradicals. A crosslinked structure can be formed by the 
recombination of the macroradicals on polymer chains under inert atmosphere. 
Poly(acrylic acid), poly(ethylene glycol), poly(vinyl alcohol) can be crosslinked using 
the method of high energy irradiation [119-123]. The swelling and permeability 
properties of the hydrogels are dependent on the radiation dose and the concentration of 
the polymer. Generally speaking, the crosslinking degree is enhanced with increase in 
radiation dose and polymer concentration. The swelling property of hydrogel is 
decreased with increasing radiation dose. Radiation-induced crosslinking has 
advantages over other methods because it can be carried out in aqueous media under 
mild conditions without toxic crosslinkers. However, biologically active agents should 
be loaded into the hydrogels after the preparation of hydrogels, which limits their 
application.  
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Crosslinking using enzymes is an interesting method to synthsize hydrgels. For 
example, PEG-based hydrogel was synthesized by adding transglutaminase to a 
solution of poly(lysine-co-phenylalanine) and PEG functionalized with glutaminyl 
groups (PEG-Qa). Transglutaminase catalyzes the reaction between PEG-Qa and lysine 
to prepare hydrogels. The hydrogel properties can be controlled by the ratio of the 
lysine copolymer to PEG-Qa [124]. 
2.2.2.2 Cyclodextrin as Crosslinker 
Low water solubility, the toxicity of drug candidates and lack of efficacy cause 
the failure during drug development. 90% of new drugs and 40% of the currently 
marketed drugs have low water solubility according to the Biopharmaceutics 
Classification System, which results in unsufficient therapeutic concentrations in 
physiological fluids [125]. Many water-soluble hydrogel systems are utilized to 
encapsulate hydrophobic drugs to obtain desirable drug interactions and drug 
pharmacokinetics [126, 127]. 
Cyclodextrins (CDs) are potential candidates for advanced dosage forms, 
because they can be used either as functional carrier materials in pharmaceutical 
formulations or for complexation [128-131]. CDs can form inclusion complexes with a 
small guest molecule both in solid state and in solution and guest molecules are 
surrounded by hydrophobic environment of CD cavity. Their capacity for forming 
inclusion complexes can be maintained and enhanced when CDs self-assemble to 
copolymerize with other compounds, crosslink together and form aggregates.  
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The chemical, physical and biological properties of small guest molecules were 
altered to eventually have the pharmaceutical potential. β-CD, the most common 
natural CD, has 21 hydroxyl groups including seven primary and 14 secondary 
hydroxyls (Figure 2.8). Functional groups can be introduced into the macrocyclic ring. 
The property of stability, dissolution rate, solubility or bioavailability of drugs is 
improved by utilizing the natural and chemically modified CDs [132-138]. Thus, the 
rational design of drug formulations is allowed by the multifunctional characteristics of 
CDs. The combination of molecular encapsulation with other carrier systems is a 
valuable method for developing new drug delivery systems [139-142].  
 
Figure 2.8. Hydroxyls located on the edge of the β-CD rings.  
Reprinted from Advanced Drug Delivery Reviews, Vol 36, F. Hirayama, K. Uekama, 
Cyclodextrin-based controlled drug release system, 125-141, Copyright (1999), with 
permission from Elsevier. License number 2957931387869. 
CDs are incorporated into a matrix structure to enhance the hydrophilicity of the 
polymer matrix and provide an affinity-based mechanism for drug loading and 
controlled drug release. Covalent linkages between CDs and chemically crosslinked 
networks make CDs fully display their complexation capabilities. CDs can be used as 
the crosslinkers and the host for drugs in chemically crosslinked networks. The 
reactive hydroxyl groups in the native CD structure and the amine, carboxylic acid 
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and hydroxyl groups in its derivatives can be utilized to prepare covalently 
crosslinked networks. Several crosslinking agents, such as ketone, isocyanate and 
epoxide groups, were evaluated [143]. 
2.2.2.3 Hydrogels in Therapeutics  
Hydrogels, as fundamental components, have been applied in various 
therapeutic applications. In the following sections, the applications of hydrogels in 
controlled drug delivery and tissue engineering are emphasized. Hydrophilic polymers 
and hydrogels are very important due to their biocompatibility, their responsiveness to 
environment and so on. In addition, micro- and nanofabrication approaches have 
attracted much attention to fabricating vascularized tissue-engineering scaffolds and to 
deliver drugs. Tissue engineering is the use of a combination of engineering and 
materials methods, suitable biochemical and physiochemical factors to replace, repair 
and regenerate tissues or organ functions and to create organs and artificial tissues for 
transplantation [144]. Scaffolds for tissue engineering provide support for cell 
proliferation and mimic the natural extracellular matrix (ECM). Differentiated function 
and new tissue generation are allowed in tissue engineering. In general, scaffolds are 
completely biodegradable so that the materials of scaffolds can be removed completely 
after new tissue is grown. In the following section, we will focus on the application in 
drug delivery.  
Hydrogels are widely applied as smart materials and structures in controlled 
drug delivery systems [82, 89, 145]. The physical and chemical properties of hydrogels 
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are engineered at molecular level to optimize the properties of hydrogels, such as 
surface biorecognition sites, biodegradability, surface functionality, enviro-responsive 
nature and permeability for controlled drug-delivery applications. The swelling 
properties of hydrogels are controlled to trigger drug release [146]. For example, a PVA 
and PEG delivery system was prepared to study the influence of swelling property on 
the drug release [122]. The density and degree of network crosslinking can be 
controlled by changing the initiation concentration, polymer composition and polymer 
chain length.  
Stimuli-responsive hydrogels have been applied in controlled drug delivery 
systems. The responses of these systems allow for drug release to be controlled by the 
environmental conditions. Typically, thermoresponsive hydrogels (e.g. PNIPAAm) are 
used to prepare drug-delivery systems which can exhibit a pulsatile release in response 
to changes in temperature [147, 148]. In addition, pH-responsive hydrogels are also 
applied in controlled-release applications. For example, PEG-containing ionic 
hydrogels which are pH-sensitive were applied for the oral delivery of insulin [149, 150] 
or calcitonin [151, 152].  
Drug-delivery systems sensitive to biological analytes were created by 
encapsulating enzymes within environmentally responsive hydrogels. For example, 
glucose-sensitive hydrogels are based on polymers encapsulating glucose oxidase 
within their network [153-155], which can be used as “smart” materials to release 
insulin in response to changes in glucose concentration.  
Molecular recognition is utilized for targeted drug delivery, enhancing 
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residence times and sustained drug delivery, which has been proved to be beneficial in 
drug delivery systems. Bioadhesive and mucoadhesive systems are utilized to enhance 
residence time, which leads to improved drug delivery [156]. Recently, delivery 
systems that mimic biological recognition processes have been seen to be beneficial in 
drug delivery applications, and these systems are useful for enhanced drug-delivery 
systems [157, 158]. 
2.2.3 Microcapsule for Cell Encapsulation 
Cell encapsulation is based on the immobilization/encapsulation of cells in a 
semipermeable membrane of a microcapsule. The semipermeable membrane protects 
cells from both the host’s immune system and mechanical stress while it allows the 
bidirectional diffusion of waste, oxygen and nutrients. Figure 2.9 shows the schematic 
representation of microcapsule.  
Cell encapsulation reduces chronic administration of immunosuppressants 
which is an important issue in organ transplantation. The immunosuppressants may 
lead to the important side effects. Biocompatible materials are required which do not 
interfere with cells. One of the important advantages of cell encapsulation is to allow 
the release of the therapeutic products for a long time giving rise to more physiological 
concentration (Figure 2.10). A semipermeable membrane allows the diffusion of waste, 
therapeutic products, nutrients, and oxygen while avoiding the entrance of antibodies 
and immune cells. The formation of a vascular network surrounding the microcapsule 
provides the necessary supply of oxygen and nutrition for the entrapped cells [159]. 
 




Figure 2.9. Schematic representation of microcapsule.  
Reprinted from Advanced Drug Delivery Reviews, Rosa Ma Hernández, Gorka Orive, Ainhoa 
Murua, José Luis Pedraz, Microcapsules and microcarriers for in situ cell delivery, Vol 62, 
711–730, Copyright (2010), with permission from Elsevier. License number 2957921028029. 
Furthermore, non-human cells can be used because of the limited supply of 
donor tissue in cell encapsulation technology. Any desired protein can be expressed by 
genetically modified cells without the modification of the host's genome. If the 
microcapsules of cells are broken, low concentration of therapeutic products does not 
cause the toxicity. Microcapsules (100~500 µm) can be implanted in close contact to 
the blood stream, which could be used in specific applications for the long-term 
functionality of the enclosed cells because of an enhanced oxygen transfer (Figure 
2.10). In addition, there is a larger surface/volume ratio in microcapsules compared to 
other scaffolds, where oxygen and nutrients' permeability can be improved. 
 




Figure 2.10. Schematic illustration of the semipermeable membrane (A) and a vascular network 
surrounding the microcapsule network (B).  
Reprinted from Journal of Controlled Release, Ainhoa Murua, Aitziber Portero, Gorka Orive, 
Rosa Ma Hernández, María de Castro, José Luis Pedraz, Cell microencapsulation technology: 
Towards clinical application, 132, 76-83, Copyright (2008), with permission from Elsevier. 
License number 2957920141633. 
2.2.3.1 Production Methods of Microcapsules 
The preparation methods of polymeric microcapsules should support cell 
viability and integrity. Adequate flux across a semipermeable membrane should be 
ensured to maintain cell survival and functions [160-162]. The choice of the method is 
dependent on parameters such as: desired release mechanisms, the acceptable process 
cost, mean particle size required and so on [163]. Many technologies have been 
proposed for the production of microcapsules such as gelation, fluid bed, emulsion 
methods, gelation, spray drying and extrusion bed.  
Gelation  
The primary structure of polymers is based on the amount and characteristics of 
functional groups in monomer. Hydrophobic interactions, electrostatic interactions and 
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hydrogen bonding are important for intra- and intermolecular associations, which are 
responsible for the formation of gels [164]. In the gelation method, the microcapsules 
are produced by the association of the polymer which is dissolved in a dispersing 
medium. In this process, a polymer rich dense phase was produced by a phase 
separation of a homogeneous solution of polymer. The shell can be crosslinked by an 
appropriate enzymatic or chemical crosslinking agent [165-168]. The three types of 
gelation are heat-set gelation, ionotropic gelation and cold-set gelation.  
The typical ionotropic gelation is cation-mediated gelation of negatively 
charged polysaccharides. Three examples of such systems are pectin, alginate, and 
carrageenan [169]. Internal gelation and diffusion setting are two main techniques 
using ionotropic gelation. In the technique of diffusion setting, a hydrocolloid solution 
is introduced to an ionic solution and gelation occurs while ions diffuse into the 
hydrocolloid solution. However, inhomogeneous gelation of microcapsules may be 
caused because of a diffusion mechanism. The disadvantage can be overcome by the 
second technique of internal gelation because crosslinking agents are dispersed before 
their activation. For example, the inactive form of ion can be activated by a change in 
pH to cause the interaction of the polymer chains [169]. Thermoresponsive polymers 
that have a LCST can undergo a heat-set gelation upon heating. In contrast with heat-set 
gelation, polymers that have an upper critical solution temperature (UCST) undergo a 
cold-set gelation [170]. Three types of interactions, polymer molecules, polymer and 
water and between water molecules, take place in polymer aqueous solution. High 
water content in temperature-responsive hydrogels leads to poor mechanical integrity 
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and potential dissolution [171]. External membranes outside the hydrogels have been 
proposed to overcome the disadvantages. In addition, chemical crosslinking and 
thermal gelation are combined to produce more stable microcapsules [172]. 
Emulsion Method 
An emulsion is a mixture of two or more liquids that consist of droplets of one 
liquid dispersed in another liquid. According to spatial distribution of the different 
phases, emulsions are classified into an oil-in-water (O/W) emulsion and a water-in-oil 
(W/O) emulsion. The liquid making up the droplets is referred to as the “internal phase”, 
“dispersed phase” or “discontinuous phase” whereas the surrounding liquid is referred 
to the “external phase”, “continuous phase” or “dispersing phase” [173]. Emulsion 
method for microcapsule production is often followed by gelation. Polymer aqueous 
solution is dispersed in an immiscible organic solvent by using surfactants in organic 
phase. After the dispersion reaches equilibrium, gelation is initiated by adding a gelling 
agent into the emulsion or by cooling. This technique is suitable for industries, since it 
is easy to scale up. However, the final particles have a wide diameter distribution [160].  
Extrusion Method 
Extrusion method is also followed by gelation. A syringe needle is used in 
extrusion method on a small scale. After the solution of hydrocolloid is loaded into the 
syringe, it is extruded through the needle to form droplets that fall into a hardening 
solution. The droplets undergo gelation by adding an appropriate reagent, cooling and 
so on. There are several factors influencing the size of the droplets, such as the polymer 
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concentration, the diameter of the needle, the viscosity of the solution, and so on. In 
order to obtain homogeneous droplets and enhance yield, several technologies are 
introduced, such as JetCutter, coaxial laminar air-flow (AirJet), vibrating nozzle, 
electrostatic potential, and so on [160, 168, 169]. Single droplets are formed at the 
nozzle tip in the techniques of coaxial air-flow and the electrostatic technique. An 
additional air-flow through an outer concentric nozzle or an electric field enhances the 
formation of droplets. The droplet diameter is adjusted by changing the nozzle diameter. 
Vibration is applied on a laminar fluid jet to achieve droplets during droplet formation 
by the vibration technology. The particle size can be adjusted mainly by wavelength 
and the nozzle diameter, while it is also influenced by the solution viscosity.  
Spray Drying 
Spray drying is the transformation of a fluid material into a dried particulate 
form by spraying the fluid into a hot drying medium [174]. It includes several stages, 
atomisation, mixing of spray and air, evaporation and product separation [163]. Air or 
an inert gas is used in the processing method. A suspension, a solution or an emulsion 
can be loaded into the sprayer [175]. The influencing factors in spray-drying are air 
outlet temperature, air inlet temperature, feed temperature and so on. The viscosity and 
fluidity of the system is influenced by feed temperature. The water content and particle 
drying rate are influenced by the air inlet temperature. Droplets of small size (10-50 µm) 
or large size (2-3 mm) are obtained depending on the operating conditions or starting 
feed material [175]. The solubility of the solute and the concentration of the feed 
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solution affect the particle sizes of the droplets during spray drying. The larger particles 
are produced by increasing the solid content of the spray solution. Furthermore, the 
crystallization form of the polymer can influence particle formation. It is easy to 
prepare hollow particles with amorphous materials and porous particles can be formed 
using crystalline polymers [176]. The hydrogel particles can be prepared by the 
rehydration of the spray-dried particles under gelling conditions. When dried particles 
are immersed in an aqueous environment, polymer chains are hydrated and dissolved 
and a polymer network is formed due to the gelling environment. The size of gelled 
microcapsules is determined by the relative kinetics of the two processes [177]. 
Therefore, spray drying offers an alternative of producing microcarriers in a continuous 
processing operation. 
Fluidized Bed 
Fluidized bed technology is an efficient way to coat a uniform layer of shell 
material onto solid particles. It is one of the few advanced technologies for coating 
particles with any kind of polymer. In conventional fluidized beds, the gravity force 
experienced by particles is compensated by an upward moving air flow. The 
fluidized-bed coating methods are classified into top-spray, bottom-spray and 
tangential spray. The bed of core particles is suspended by the air and the coating 
solution is sprayed onto the fluidized particles against the current. The coated particles 
travel through the coating zone into the expansion chamber, fall back into the product 
container, and continue to cycle throughout the process. Microcapsules produced by 
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typical fluidized bed equipment are from 100 µm to a few millimeters [168, 178]. The 
gelation step can be followed by this technique.  
2.2.3.2 Materials for Cell Encapsulation 
Many types of natural and synthetic polymers are explored to find a suitable 
material to improve microcapsule and microcarrier design. For our literature review, we 
will focus on alginate, gelatin and agarose.  
Alginate 
Alginate extracted from brown seaweed is a water-soluble linear polysaccharide 
which is composed of alternating 1–4 linked α-guluronic (G) and β-d-mannuronic acid 
(M) residues. The geometries of M-block, G-block and alternating regions are different 
due to the particular shapes of the different monomers and their modes of linkage in 
polymer. A diamond shaped hole forms while two G-block regions are aligned. The 
dimensions of the holes are ideal for the cooperative binding of calcium ions. Calcium 
can induce dimeric association of two G-block regions. The properties of these 
inter-chain associations depend on the amount of calcium. 
Temporary associations give rise to highly viscous solutions with calcium ions 
at a low concentration. In contrast, gelation or precipitation takes place at calcium ions 
at a high concentration, which results in the permanent associations of the alginate 
chains. The alginate functional properties of biodegradability, biocompatibility and gel 
strength are influenced by the cation, molecular size and chemical structure [179, 180]. 
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The biocompatibility of alginate depends on its purity which is influenced by 
contamination or the industrial extraction process. Examples of the impurities are 
endotoxins, certain proteins and polyphenols. An effective contaminant reduction 
method is size exclusion chromatography [181]. Therefore, an efficient purification 
process to remove contaminants is very important [182]. Other desirable properties of 
alginate microparticles include defined pore size, high mechanical and chemical 
stability, controlled swelling and mechanical properties [183]. 
The mechanical properties are influenced by G content and arrangement, G 
block length and molecular weight of alginate chains. Alginate polymer with more G 
content yields strong and ductile hydrogels. M blocks are flexible and extensible 
compared to G blocks. The concentrations of alginate polymer and different gelling 
agents also influence the mechanical properties of the microparticles [184].  
Alginate solution was dripped into aqueous solution of calcium ions to form 
alginate gel microparticles. The fast gelation rate of CaCl2 leads to varied crosslinking 
degree and a polymer concentration gradient within the gel microparticles. CaCO3 with 
low water solubility allows its uniform distribution in alginate solution before gelation 
[185]. Calcium-alginate microparticles are sensitive towards nongelling agents and 
chelating agents. In physiological solution, this ion replacement inevitably leads to 
osmotic swelling of the particles and results in increased pore size and destabilization 
of the microgel. 
Compared to Ca2+ and Sr2+, Ba2+ has a high affinity to alginate crosslinking 
binding sites. In addition, the affinity of gelling agents is dependent on the alginate 
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composition. For high-G alginate, the use of barium ion led to increased strength and 
stability of microparticles. For high-M alginate, no beneficial effect was observed on 
permeability or stability [186-188]. Alginate particles can be stabilized with a 
polycation such as poly-l-lysine (PLL) after gelation. PLL binds to alginate chains after 
suspending microparticles in PLL solution [165, 167]. These polyelectrolyte complexes 
are not sensitive to calcium chelators or non-gelling cations. Since charged PLL is 
immunogenic, alginate was coated on the PLL-coated alginate microparticles to form a 
alginate-PLL-alginate (APA) system [189]. Compared to other polycations such as 
poly-l-ornithine (PLO), [190] chitosan, [191] lactose modified chitosan [192] and 
poly-d-lysine (PDL), PLL is the best option available [193].  
The swelling behaviour of alginate systems is influenced by other chemical 
modifications. For example, alginate tyramine conjugate crosslinked by calcium ions 
swelled less than in unmodified alginate [194]. Alginate microparticle size is another 
key issue. Small-size microparticles led to higher transportation, improved mechanical 
strength and better dispersion [195, 196]. 
In fact, cells can’t survive in the center of cell clusters in large microcapsules 
due to the limitation of oxygen and nutrients diffusion, which requires size control of 
the microcapsules [197, 198]. The microparticle size is related to the production 
method. The traditional production method for alginate systems is to extrude the 
polymer solution into a gelling agent solution to induce gelation. Other techniques have 
been applied in order to achieve size control of alginate microparticles. For example, a 
novel microfluidics device has been developed to produce 50–200 µm calcium alginate 
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beads. This device enabled droplets to encapsulate human kidney 293 cells into calcium 
alginate beads [196]. Encapsulated Chinese hamster ovary cells in larger microcapsules 
had a lower growth rate that those in 150 µm microcapsules due to their effective 
scaffold surface area and high diffusion efficiency [195]. The technique that can control 
the properties of microparticles is compatible with various cell lines. Chondrocytes 
were applied to the treatment of articular injury [199-203]. In this technique, 
chondrocytes were successfully expanded in vitro before implantation [204]. 
Embryonic stem cells (ESCs) profit from alginate microcapsule technology. Currently, 
the common expansion of ESCs in two-dimensional cell culture systems is limited by 
the surface area.  
Moreover, extracellular matrix proteins are used to precoat the culture surface. 
The expensive and labor-intensive 2D culturing methods cannot meet the market 
demand for ESCs. Alginate three-dimensional (3D) systems have been introduced in 
stem cell culturing to overcome these shortcomings. The advantages of these systems 
include high specific area, control over permeability and so on. Thus, such matrices can 
provide cells with a biomimetic environment [205]. Alginate microsystems enable the 
differentiation and proliferation of ESCs into insulin-producing cells. Compared to 2D 
systems, alginate 3D systems increase the efficiency of ESC differentiation in terms of 
insulin productivity [206]. Alginate systems for ESCs can also retain pluripotency. The 
hESCs encapsulated in calcium alginate/gelatin microparticles were cultured in 
maintenance medium for 260 days [207]. Besides ESCs and chondrocytes, alginate 
microparticles have been assayed for other cell types inclusive of keratinocytes [208], 
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epithelial [209], pancreatic [210, 211], fibroblasts [212], hepatic cells [213, 214], 
myoblasts[215, 216] and so on.  
Alginate microparticles can be modified with molecules for different types of 
cells to improve cell adhesion. For example, matrigel introduced to alginate 
microparticles increases proliferation of the cells and enhances the ability to secrete 
bioactive factors [217]. In addition, the conjugation of the fibronectin-derived adhesion 
peptide arginine-glycine-aspartic acid (RGD) to alginate molecules improves its 
interaction with the integrin receptors of the enclosed cells and enhances their survival 
and functionality [218]. 
Gelatin 
Gelatin is a natural, biocompatible and biodegradable macromolecule which is 
produced by partial hydrolysis of collagen derived from white connective tissue, skin 
and bones of animals such as pigs and cattle. The physical properties of gelatin are 
dependent on the processing conditions of manufacturing and the properties of the raw 
materials [219]. Recombinant gelatins were introduced to eliminate many of the 
drawbacks with tissue-derived material. This technology allows the production of 
gelatins with the ability to tailor the molecule, guarantee reproducibility and define 
molecular weight.  
Gelatin forms a thermoreversible gel by temperature reduction. Upon cooling, 
these coils undergo a coil-to-helix transition, leading to gelation [169]. Gelatin 
microparticles undergo reverse thermal gelation with increasing temperature due to its 
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thermal gelation characteristics. So crosslinking should be used in the production of 
gelatin microcapsules. GTA has been used as a crosslinker to prepare stable gelatin 
microparticles. For example, fibroblasts were seeded on porous gelatin microparticles 
(100–230 µm). In vivo results showed that the multifunctional microparticle can act as 
a protein release vehicle, a culture substrate, and a biodegradable scaffold [220].  
Gelatin was mixed to other polymers to bypass the use of chemical crosslinker. 
For example, mESCs were encapsulated by gelatin/alginate particles by 
extrusion/cation gelation. The results indicated that this could enable the production of 
a 3D mineralized tissue from ESCs [221].  
Commercial microparticle products are assayed as gelatin carrier for cell 
delivery. CultiSpher® (Percell Biolytica AB, Sweden) microparticles with a diameter of 
about 100–400 µm consist of an extensively crosslinked matrix of type-A porcine 
gelatin. Human fibroblasts could be seeded on these gelatin microcarriers as a 
transplantation vehicle and a support for tissue regeneration in vivo [222]. 
Agarose 
Agarose, a readily available neutral polymer, is extracted from marine red algae 
consisting of alternating units of 3,6-anhydro-α-L-galactopyranosyl and 
β-D-galactopyranosyl units. Agarose is a thermoresponsive hydrogel that undergoes 
gelation with decreasing temperature. The mechanical properties of agarose hydrogels 
are influenced by the cooling rate and the agarose concentration [189, 223]. Sol–gel 
transition may occur in a temperature range from 10 to 40 °C and melting requires 
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heating above 95 °C. This hysteresis is due to the aggregation of helices [224]. Agarose 
is used to entrap cells because of its temperature sensitive gelation. Typically, the 
microparticles encapsulating cells are prepared by extrusion of droplets hardened by a 
reduction in temperature after cell/agarose suspension was transformed into droplets. 
Agarose microparticles were also prepared by a water-in-oil technique and agarose 
aqueous solution was dispersed in oil via shaking or mechanical stirring. The agarose 
droplets are also hardened by a reduction in temperature [225]. In addition, a 
microfluidic device was used to produce agarose droplets in the range of 50 to 110 µm. 
Agarose droplets encapsulating cells were collected and the gelation of the droplets was 
carried out by cooling the sample using an ice bath. The size of the microcapsules 
produced was smaller than those produced by the conventional emulsion method.  
A layer-by-layer polyelectrolyte coating on the microparticle surface could 
tailor the transport property of the microparticles. A coating of silica nanoparticles 
could enhance the mechanical strength of the capsules. Yeast cells were encapsulated 
into such agarose capsules [225]. 
Recently, agarose microcapsules were produced with a single hollow core 
template by alginate microparticles. Feline kidney cells were encapsulated by alginate 
microparticles of about 150 µm in diameter as template and agarose microcapsules 
were prepared. These microcapsules maintain better cell proliferation than alginate 
microcapsules. In addition, mESCs were enclosed in the microcapsules. Embryoid 
body-like spherical tissues were formed in the hollow cores of the microcapsules [226]. 
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2.3 Concluding Comments 
The above literature review showed that gelatin-based biomaterials could be 
very useful for drug and cell delivery that have various promising applications. 
However, as can be seen from the above literature review, lots of efforts need to be 
taken to exploit the delivery applications of gelatin-based biomaterials. 
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CHAPTER 3 A MICELLAR COMPLEX FORMED FROM 
GELATIN-BASED GRAFT COPOLYMERS FOR DRUG 
DELIVERY 
3.1 Introduction  
Polymeric micelles possessing a core/shell structure for drug delivery have 
received considerable attentions in the past decade owing to their advantages over other 
particular drug carriers [1]. Temperature-responsive micelle, as a stimuli-responsive 
micelle, is one of the most interesting polymeric micelles. PNIPAAm exhibiting a 
LCST of about 32 °C is the most studied temperature responsive polymer [2]. 
Hydrophilic copolymers containing PNIPAAm segments are capable of 
self-assembling into colloidal aggregates, such as vesicles [3], micelles [4] and so on. 
The drug release behavior responsive to temperature can be controlled well while 
designing a new self-assembled micelle or vesicle system composed of a 
PNIPAAm-based copolymer.  
PNIPAAm-based polymeric micelles with small sizes (<200 nm) can be used to 
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solubilize hydrophobic drugs in their hydrophobic inner cores, while their hydrophilic 
shells are exposed to the external environment. With polymeric micelles with 
PNIPAAm-based copolymer as the shell or core, both active and passive targeting to 
tumors can be achieved through external temperature changes and an enhanced 
permeability and retention effect (EPR effect) [5]. However, the non-degradable 
polymeric micelles based on PNIPAAm may raise the elimination issue of micelles 
from body in biomedical applications [6]. Recently, hydrophobic polyesters were 
introduced into PNIPAAm-based copolymers in drug delivery applications because of 
the biodegradability and biocompatibility of the polyester blocks. For example, 
Poly(lactide) (PLA) [7], poly(ε-caprolactone) (PCL) [8]  and 
poly(lactide-co-glycolide) (PLGA) [5] have been used as the hydrophobic 
core-forming segments for fabrication of micelles while PNIPAAm segments were 
used as the shell-forming segments. However, there was less focus on the degradability 
of micelle with PNIPAAm as core-forming segment [9]. The shell-forming segments 
can be designed to obtain the desirable properties of micelles. Gelatin, a natural 
material, has been applied in the preparation of micelles [10] as drug carriers in 
pharmaceutical field due to its biodegradability [11], biocompatibility [12], and 
hydrophilicity. In addition, the electrical nature of gelatin is a unique advantage of 
gelatin which can be utilized to prepare drug carriers for controlled drug release [13, 
14].  
It is desirable that polymeric micelles exhibit prolonged activity in the 
systemic circulation by avoiding the scavenging of the reticuloendothelial systems 
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(RES) [15]. The stability of micelle is an important issue. PEG is the most studied one 
which has highly hydrated hydrophilic chain to stabilize interface between the 
hydrophobic core and the medium. Usually, PEG was conjugated to the copolymer 
containing PNIPAAm segment. However, this reduced the number of polymer 
candidates for polymeric micelles. Three layered micelles, such as core–shell–corona 
(CSC) micelles, have attracted a lot of interest in controlled drug release in the past 
decade [16]. ABC triblock copolymers were usually used to prepare CSC micelles and 
applied as a drug carrier [17]. Another preparation method of a CSC colloidal 
dispersion is complexation between core–shell micelles and a linear polymer [18]. The 
CSC colloidal dispersion has several advantages over conventional micelles, such as 
multifunction based on the integrity of each component in micellar complex and wide 
application.  
In this work, we have designed a micellar complex (Scheme 3.1) 
self-assembled from methoxy poly(ethylene glycol)-b-poly(2-(dimethylamino) ethyl 
methacrylate) (MPEG-PDMAEMA) diblock copolymer and PNIPAAm-grafted gelatin 
(NGG) graft copolymer as a new class of drug delivery system. The temperature 
sensitivity of the PNIPAAm-grafted gelatin was demonstrated by nuclear magnetic 
resonance (NMR) characterization and LCST measurement. The micellar complex 
was analyzed by dynamic light scattering (DLS) and transmission electron microscopy 
(TEM). The screening efficiency of the corona was studied through degradation and 
stability analysis. The feasibility of delivering anticancer drug via the thermosensitive 
micellar complex was demonstrated using methotrexate (MTX) as a model drug. The 
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cellular uptake behavior of micellar complex was investigated using confocal laser 
scanning microscopy (CLSM) after the micellar complex was labeled with fluorescein 
isothiocyanate (FITC), a fluorescent probe often used for cell imaging. Quantification 
of the cytotoxic response of L929 cells to the synthesized copolymers was performed 
using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. 
Herein, we demonstrate that the thermosensitive micellar complex could be used as an 
efficient drug delivery system for controlled drug delivery. 
 
Scheme 3.1. Schematic illustration for preparation of the core-shell-corona micellar complex 
from PNIPAAm-grafted gelatin and MPEG-PDMAEMA. 
3.2 Experimental Section 
3.2.1 Materials 
Gelatin from porcine skin (type A, 300 g bloom), (+)Sodium L-ascorbate 
(BioXtra, ≥99.0% (NT), Fluka), Copper(II) bromide (purum p.a., ≥98.0% (RT), 
Sigma-Aldrich), 1,1,4,7,10,10-Hexamethyltriethylenetetramine (HMTETA, 97%, 
Aldrich), N-isopropylacrylamide (NIPAAm, 97%, Aldrich), α-Bromoisobutyryl 
bromide (BiB, 98%, Aldrich), FITC, and (2-dimethyl amino)ethyl methacrylate 
(DMAEMA, ≥98%) were supplied by Sigma-Aldrich. Triethylamine (TEA) and 
MPEG PDMAEMA
MTX
Dialysis at 40 °C 
for 16 h
Gelatin PNIPAAm
Dialysis at 40 °C 
for 8 h
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Acetone was obtained from Fluka. Tetrahydrofuran (THF) and dimethylformamide 
(DMF) were purchased from Merck. Sodium hydroxide was purchased from GCE 
laboratory chemicals. PEG and PEG methyl ether with average molecular weight of 
2000 Da were purchased from Aldrich Co. D2O used as a solvent in the NMR 
measurements were obtained from Cambridge Isotope Laboratories, Inc. The 
monomers, NIPAAm and DMAEMA, were used after removal of the inhibitors in a 
ready-to-use disposable inhibitor-removal column (Aldrich). All other reagents were 
purchased from Sigma-Aldrich unless otherwise stated. 
3.2.2 Synthesis Methods 
3.2.2.1 Synthesis of PNIPAAm-grafted Gelatin 
Gelatin was dissolved in NaOH aqueous solution (pH=13.8) at 37 °C with the 
concentration of 5 wt%. The solution was adjusted to pH 7 through titration after 1 h at 
24 °C. The neutralized solution was dialyzed against double distilled water (ddH2O) for 
36 h at 24 °C. The forming precipitate was removed with filter paper. Then, the clear 
hydrolysate solution was lyophilized. The yield was 61% and the number-average 
molecular weights of gelatin and gelatin hydrolysate are 42700 and 3200, as 
determined by gel permeation chromatography (GPC). 
1 g gelatin hydrolysate was dissolved in 20 mL dimethylsulfoxide (DMSO, 
anhydrous) in a 100 mL round-bottom flask. The reaction mixture was heated to 
dissolve the gelatin hydrolysate completely. The flask cooled down to 24 °C. BiB (0.8 
mL, 6.5 mmol) was added dropwise to the flask with a syringe at a rate of 0.1 mL per 
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10 min. The reaction proceeded at 24 °C for 48 h. The reaction was stopped by 
precipitating the reaction mixture in THF. The precipitate was separated with centrifuge. 
The crude product was washed with THF three times. The organic solvent was removed 
in vacuum at 50 °C overnight. The yield was 32.6%.  
0.2 g gelatin initiator (starting points: 1.48×10-4 mol) and NIPAAm were 
dissolved in 20 mL a mixed solvent of ddH2O and IPA (volume ratio=1:1) in a 50 mL 
flask equipped with a stirring bar. It was deoxygenated by degassing with nitrogen gas. 
After 20 min, the reducing agent (+)-Sodium L-ascorbate (10000 ppm vs monomer) 
was added to the reaction mixture. After the reaction mixture was degassed for 40 min, 
CuBr2 (100 ppm vs monomer)/HMTETA (100 ppm vs monomer) in a mixed solvent of 
ddH2O and IPA (volume ratio=1:1) was added as soon as possible. The reaction was 
held at 24 °C overnight. The polymerization was stopped by opening the flask and 
exposing the catalyst to air. The reaction mixture was lyophilized after IPA was 
removed through rotary evaporation. The lyophilized residue was dissolved in 
chloroform and precipitated in ether. The product was dried in vacuum at 50 °C 
overnight. 
3.2.2.2 Synthesis of MPEG-PDMAEMA 
MPEG (1 g, 0.5 mmol) was dissolved in 15 mL anhydrous THF in a 50 mL 
round-bottomed flask. After the MPEG was dissolved, BiB (0.625 mL, 5 mmol) was 
added to the flask with syringe at a rate of 0.1 mL per 10 min. TEA (0.7 mL, 5 mmol) 
was dissolved in 5 mL THF. After addition of TEA solution, the reaction was allowed to 
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proceed at room temperature for 24 h. the reaction was stopped through exposing it to 
air for 1 h. The resulting precipitate in reaction mixture was removed by centrifugation. 
Clear solution was precipitated in hexane. The crude product was redissolved in THF 
and reprecipitated in hexane to remove any residual reactants. The MPEG-Br 
macroinitiator for the subsequent ATRP was dried at 50 °C in vacuo overnight. The 
yield was 85.7%.  
50 mL round-bottomed flask containing a stir bar was charged with DMAEMA 
(0.24 mL, 1.42 mmol), a mixed solvent of ddH2O and IPA (volume ratio=1:1, 14 mL) 
and MPEG initiator (0.097 g, 0.044 mmol). It was deoxygenated by degassing with 
nitrogen gas. After 20 min, the reducing agent, (+)-Sodium L-ascorbate (10000 ppm vs 
monomer), was added to the reaction. After the reaction mixture was degassed for 40 
min, a solution of CuBr2 (100 ppm vs monomer) and HMTETA ligand (100 ppm vs 
monomer) in a mixed solvent of 7 mL ddH2O and 7 mL IPA was added as soon as 
possible. The reaction was held at 60 °C overnight. The polymerization was stopped by 
opening the flask and exposing the catalyst to air. The reaction mixture was dialyzed 
against ddH2O with dialysis membrane (MWCO 6000-8000) for 24 h. At last, the 
MPEG-PDMAEMA was obtained through lyophilization. The yield was 48%.  
3.2.3 Characterization Methods 
GPC with organic solvent was carried out with a Shimadzu CBM-20A and 
LC-20AD system equipped with two Phenogel 5 μm 100 and 1000 Å columns (size: 
300 × 4.6 mm) in series and a Shimadzu RID-10A refractive index detector. THF was 
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used as eluent at a flow rate of 0.3 mL/min at 40 °C. Monodispersed polyethylene 
glycol and polyethylene oxide standards were used to obtain a calibration curve. GPC 
with aqueous solvent was carried out with a Shimadzu SCL-10AVP and LC-10ATVP 
system equipped with two Ultrahydrogel 6 μm 120 and 250 Å columns (size: 300 × 7.8 
mm) in series and a Shimadzu RID-10A refractive index detector. Phosphate buffer 
solution (PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Phosphate buffer, pH=7.4) was 
used as eluent at a flow rate of 0.5 mL/min at 37 °C. Monodispersed polyethylene oxide 
standards were used to obtain a calibration curve. 
The 1H NMR (400 MHz) spectra were recorded on a Bruker AV-400 NMR 
spectrometer at room temperature. The 1H NMR measurements were carried out with 
an acquisition time of 3.2 s, a pulse repetition time of 2.0 s, a 30° pulse width, a 5208 Hz 
spectral width, and 32 K data points. Chemical shift was referred to the solvent peak 
(δ=4.7 ppm for HOD).  
3.2.4 LCST Determination 
The LCSTs of PNIPAAm-grafted gelatin aqueous solutions were measured 
using the cloud point measurement (turbidimetry) method [19, 20]. Briefly, cloud 
points were measured with a UV-vis spectrophotometer. Aqueous copolymer solutions 
(1 mg/mL) were heated from 25 to 40 °C at 2 °C/min while both the transmittance at 
500 nm (1 cm path length) and the solution temperature were monitored. Data was 
collected after transmittance was stable at various temperature points. LCST was 
defined as the temperature at which optical transmittance of aqueous copolymer 
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solution decreased 50%. 
3.2.5 Preparation and Characterization of Micelles and Micellar complexes 
2.5 mg PNIPAAm-grafted gelatin was dissolved in a mixed solvent of 1 mL 
ddH2O and 1 mL DMF to prepare a copolymer solution. The two copolymer solutions 
were passed through a 0.22 µm pore-sized syringe filter. PNIPAAm-grafted gelatin 
solution was dialyzed against ddH2O and the water was slowly heated from 24 °C to 
40 °C in 20 min. At 8 h, 1 mL of MPEG-PDMAEMA solution (2.5 mg mL-1) was added 
into the dialysis tube. Dialysis was continued for another 16 h. Water was replaced 
every 4 h. After dialysis, the micellar solution was collected and the micellar complexes 
were obtained with rotary evaporation. The micelle was prepared according to the 
above method and no MPEG-PDMAEMA was added. FITC labeled micellar 
complexes were prepared using the solution containing MPEG-PDMAEMA (2 mg 
mL-1) and FITC-PEG-PDMAEMA (0.5 mg mL-1) instead of MPEG-PDMAEMA (2.5 
mg mL-1) according to the above method.  
Measurements of micelle size and zetapotential were performed on micellar 
solution at 37 °C using a Zetasizer Nano ZS (Malvern Instruments, Southborough, MA) 
with a laser light wavelength of 633 nm at a 173° scattering angle at a concentration of 
0.1 mg mL-1. The micelles and micellar complexes were imaged on a Philips 300 kV 
Transmission Electron Microscope. We prepared the samples for TEM by depositing 
one drop of sample solution (0.1 mg mL-1) onto a 200 mesh carbon coated copper grid. 
It was dried at 45 °C overnight and stained with 0.05 wt% of phosphotungstic acid 
 




3.2.6 Stability of Micelles and Micellar Complexes in FBS Solution  
The stabilities of micelles and micellar complexes in the presence of serum in 
PBS buffer were determined by DLS [22]. The micellar solution was incubated at 
37 °C and particle size was measured at predetermined time interval, defined as ti. The 
average diameter of micelles in PBS buffer before FBS treatment, defined as t0, was 
also measured. The ratio of particle sizes was calculated as ti/t0. The concentration of 
micelles or micellar complexes was 0.1 mg mL-1 and the concentration of FBS was 20% 
v/v. The size of micelle was measured as a function of time at 37 °C using a Zetasizer 
Nano ZS (Malvern Instruments, Southborough, MA). 
3.2.7 Degradation of Micelles and Micellar Complexes 
The degradation of gelatin in micelles or micellar complexes in the presence of 
collagenase was determined by DLS. The micelles and micellar complexes were 
prepared using the dialysis method. The micelles were dissolved in PBS buffer with 20 
units mL-1 of collagenase and incubated at 37 °C. At various time intervals, the particle 
sizes of micelles and micellar complexes were also measured using a Zetasizer 
Nano ZS (Malvern Instruments, Southborough, MA).  
3.2.8 Drug (Methotrexate) Loading and Release 
1 mL PNIPAAm-grafted gelatin solution (2.5 mg mL-1) was mixed with 1 mL 
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MTX solution in DMF (0.5 mg mL-1). The solution was dialyzed against 1 L ddH2O 
with dialysis membrane (MWCO: 2000 g/mol) at 40 °C. 8 h later, 1 mL 
MPEG-PDMAEMA aqueous solution (2.5 mg mL-1) was added into the micelle 
solution in dialysis tube. Dialysis was continued for another 16 h. Water was replaced 
every 4 h. To determine the loading efficiency and loading level, part of the micellar 
solution after dialysis was lyophilized. The lyophilized residue was dissolved in DMF 
and the ultraviolet (UV) absorbance at 372 nm was measured. The weight of MTX 
was calculated according to the calibration curve at the wavelength of 372 nm. 
For in vitro drug release study, 0.75 mL micellar complex solution containing 
0.03 mg MTX was loaded into 0.6-mL microcentrifuge tube. The microcentrifuge tube 
was sealed with dialysis membrane (MWCO: 2000 g/mol) and rubber band. The 
prepared device was immersed into 13 mL PBS buffer in 15 mL centrifuge tube which 
was shaken at 40 rpm at 25 or 37 °C. 1 mL the PBS buffer was replaced with fresh one 
at predetermined time intervals. The amount of MTX released from micelles was 
measured based on the UV absorbance of the replaced PBS buffer at 372 nm and 
calculated with the calibration curve at the wavelength of 372 nm. 
3.2.9 Cancer Cell Internalization and Imaging of Micellar Complexes 
HeLa cells were seeded on Lab-Tek chamber slide (8 well glass slide) 
(Nalge-Nunc International, USA) at a density of 5х104 cells per well for 24 h and 
treated with FITC labeled NGED2 micellar complexes at a concentration of 0.1 mg 
mL-1 [23]. At predetermined time intervals, the cells were washed 3 times with PBS 
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buffer and fixed with 0.2 mL 4% paraformaldehyde in phosphate buffer (pH 7.4) for 30 
min at 37 °C. After paraformaldehyde was removed and washed 3 times with PBS 
buffer, 4,6-Diamidino-2-phenylindole (DAPI) was used to counterstain the nucleus for 
15 min and the staining was terminated by washing the cell monolayer three times with 
PBS. Accumulated FITC-labelled micellar complex in Hela cells were localized using a 
laser scanning confocal microscope (LSM 410, Carl Zeiss, USA). Excitation and 
emission wavelengths were 364 and 461 nm for DAPI and 488 and 518 nm for FITC. 
50 cells were selected from 5 pictures for FITC fluorescence intensity measurement 
using software ImageJ. 
3.2.10 Cytotoxicity Evaluation 
In vitro cytotoxicity tests on the copolymer were performed by MTT assay in a 
96-well cell culture plate. L929 mouse fibroblasts were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM) containing 10% FBS and 1% 
penicillin/streptomycin (PS) for 24 h. Cells grew as a monolayer. L929 cells were 
harvested from culture plate by incubating in trypsin solution for 5 min. Cells were 
centrifuged and the supernatant was discarded. Cells were resuspended in DMEM at a 
density of 1105 cells mL-1 and were cultured at 1104 cells per well in 96-well plates 
at 37 °C in a humidified atmosphere of 5% carbon dioxide (CO2). The DMEM in 
96-well plate was changed with 0.1 mL the copolymer solution in the DMEM 24 h after 
cells were cultured. The copolymer solution was prepared after the copolymer was 
sterilized under UV light for 30 min. The plates were incubated at 37 °C in a 
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humidified 5% CO2 atmosphere. After 24 h, 10 µL MTT solution (5 mg mL-1) was 
added to each well. After 4 h of incubation at 37 °C, the DMEM containing MTT was 
removed and the insoluble formazan crystals that formed were dissolved in 0.1 mL 
DMSO. The absorbance of the formazan product was measured at 570 nm using a 
microplate reader (FLUOstar OPTIMA, Labtech).  
3.3 Results and Discussion 
3.3.1 Synthesis and Characterization of PNIPAAm-grafted Gelatin 
Gelatin is a traditional water-soluble functional protein of high interest and 
value. Gelatin presents a structure with variable physical properties and chemical 
heterogeneity due to the differences in collagen sources and preparation techniques 
[13]. An important problem with gelatin is an apparent fall of its solubility in organic 
solvents such as DMSO. In this study, we use alkali treatment method to cleave the 
molecular chain of gelatin. After the molecular weight changed from Mn 42700 to Mn 
3200, its solubility in DMSO was enhanced remarkably. The starting 
bromo-terminated gelatin initiator for activators regenerated by electron transfer for 
atom transfer radical polymerization (ARGET ATRP) was prepared from gelatin 
hydrolysate by the reaction of the hydroxyl end groups of gelatin hydrolysate with BiB 
(Scheme 3.2). The existence of Br in gelatin initiator and C/Br ratio were determined 
with high-resolution X-ray photoemission spectroscopy (XPS). The number of Br in 
gelatin initiator was 2.45 calculated from the data of XPS and elemental analysis. So 
the number of PNIPAAm graft chains per gelatin molecule is 2.45.  
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Scheme 3.2. Synthesis routes and chemical structures of PNIPAAm-grafted gelatin and 
MPEG-PDMAEMA. 
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PNIPAAm-grafted gelatin was synthesized in a mixed solvent of ddH2O and 
isopropanol (IPA) at 24 °C overnight (Scheme 3.2). The structure of PNIPAAm-grafted 
gelatin was confirmed by 1H-NMR spectra (Figure 3.1). In the spectra, all proton 
signals (=1.05, 1.47, 1.92, and 3.8 ppm) belonging to PNIPAAm segments were 
confirmed. The other peaks were assigned to gelatin. A series of graft copolymers with 
different PNIPAAm block lengths were synthesized. The molecular weights of the graft 
copolymers are tabulated in Table 3.1. The polymerization displayed some, but not all, 
of the characteristics of a controlled process [24]. The rather high polydispersity index 
(PDI=Mw/Mn) which is more than 1.5 suggests several possibilities [25]: (1) initiation 
may be too slow, (2) dead polymer chains are present, (3) the rates of activation and 
deactivation are not enough, and (4) there may be involved more than one metal 
complex for Cu(I) and/or Cu(II). In our polymerization system, the high PDI may be 
due to less Cu catalyst. Less Cu may result in the low rates of activation and 
deactivation [26]. 
Table 3.1. Molecular weights of PNIPAAm-grafted gelatin copolymers 
 
 a Poly(N-isopropylacrylamide)-grafted gelatin was denoted by NGGx. x is the number of the 
copolymer.  
 b Determined by GPC.  









NGG1 33 12200 1.66 31
NGG2 67 20100 1.66 59
NGG3 140 35700 1.68 115
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of the graft copolymer. At low temperature, the peaks assigned to the gelatin and 
PNIPAAm segments were sharp and well-defined. With increasing temperature, the 
peaks assigned to PNIPAAm were collapsed in comparison with those observed at low 
temperature, but the peaks belonging to gelatin were shown as sharp peaks like them at 
low temperature. The collapsed peaks in NMR spectra of NGG2 copolymer in D2O 
indicate the hydrophobicity of PNIPAAm. The molecular motion was restricted by the 
hydrophobic interaction of the PNIPAAm in PNIPAAm-grafted gelatin [27]. The 
phase transition from hydrophilicity to hydrophobicity is necessary for micelle 
formation. 
 
Figure 3.1. 1H NMR spectra of NGG2 copolymer in D2O at different temperatures. 
3.3.2 Synthesis and Characterization of MPEG-PDMAEMA 
Recently, another group has synthesized MPEG-PDMAEMA diblock 
5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
24 °C
37 °C
5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm0.0
 
Chapter 3 A Micellar Complex from Block and Graft Copolymers for Drug Delivery 
84 
 
copolymer [28]. In our work, MPEG-PDMAEMA was synthesized using MPEG 
initiator by a novel method of ARGET ATRP (Scheme 3.1). The structure and 1H 
NMR spectra of MPEG initiator and MPEG-PDMAEMA copolymer were shown in 
Figure 3.2. The peaks at 2.3 and 2.7 ppm were belonging to PDMAEMA blocks. The 
peak at 3.6 ppm was assigned to the methylene protons of PEG blocks. In our work, 
the polymerization degree of block PDMAEMA was determined to be 39.4 with 1H 
NMR data. 
 
Figure 3.2. 1H NMR spectra of MPEG initiator and MPEG-PDMAEMA in D2O at room 
temperature. 
3.3.3 LCST Determination  
The copolymer was water-soluble at 25 °C since both PNIPAAm and gelatin 
4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm4.5
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were hydrophilic. Negative entropy dominates the exothermic enthalpy of the 
hydrogen bonds formed between PNIPAAm polar groups and water molecules when 
the temperature was increased above LCST. The specific water orientations around 
polymer blocks were destructed thermally, i.e. dehydration, which facilitates 
polymer-polymer hydrophobic interactions. Dehydration was initiated at the ends of 
the copolymers which could act as nuclei to accelerate further polymer dehydration, 
resulting in precipitation of polymer solution at high concentration. These 
hydrophobic segments acting as nuclei rapidly triggered polymer phase transition [29]. 
UV-vis spectrophotometer was used to detect the thermosensitivity of the copolymer. 
It was used to observe the change in the transmittance of the copolymer solution as a 
function of temperature. Below LCST, PNIPAAm was a hydrophilic water-soluble 
polymer and the transmittance was about 100%. Around LCST, the transmittance 
decreased sharply because PNIPAAm became hydrophobic to form white precipitate 
in aqueous solution. Above LCST, PNIPAAm precipitates out of the aqueous solution.  
The incorporation of hydrophilic gelatin increased LCST of the graft 
copolymer as compared with pure PNIPAAm polymer [2]. Hydrophilic groups in 
PNIPAAm-grafted gelatin stabilized polymer in water by strengthening interactions 
between polymer chains and water [30]. The polymer/solvent interaction was related 
to the hydrophilic/hydrophobic balance of the copolymers [27]. With the increase of 
PNIPAAm chain length, the thermoresponsive segments of PNIPAAm dominated the 
hydrophilic segments of gelatin. The copolymer/water interaction was reduced when 
increasing temperature. In this work, LCST value decrease from 35.4 to 34.4 °C 
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whereas the PNIPAAm block length increases from 31 to 115 (Figure 3.3). 
 
Figure 3.3. % transmittance at 500 nm of 1 mg/mL aqueous solutions of PNIPAAm-grafted 
gelatin copolymers at different temperatures. 
3.3.4 Preparation and Characterization of Micelles and Micellar Complexes 
PNIPAAm-grafted gelatin is a thermosensitive copolymer. The micelles and 
micellar complexes were prepared by dialysis method [31, 32]. Micellar complexes 
were formed through the interaction between positively charged PDMAEMA block and 
negatively charged gelatin on the micelles. The inner core of the micelle structure was 
designed to be biodegradable and sensitive to temperature. PNIPAAm is well known to 
undergo a phase transition to form a hydrophobic aggregate above its LCST. 
Biodegradable gelatin was used as a hydrophilic shell in graft copolymer micelle. 
Introducing the diblock copolymer (MPEG-PDMAEMA) was introduced into the 
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micelle. And the functional characteristics of the two copolymers would be integrated.  
PNIPAAm-based micelles tended to aggregate due to either PNIPAAm chain 
entanglements or hydrophobic association of the micelles [21]. Some of 
PNIPAAm-based micelles were aggregated at the bottom of the dialysis tubing in the 
dialysis preparation method at 40 °C [33]. The presence of gelatin backbone and outer 
shell of MPEG-PDMAEMA weakened hydrophobic associations to prevent 
aggregation of micelles or micellar complexes in water. It was observed that there was 
no precipitate at the bottom of the dialysis tubing during the preparation of micelles or 
micellar complexes.  
The formation of the micelles and micellar complexes was confirmed using 
DLS instrument (Zetasizer Nano-ZS, Malvern Instruments). The sizes and zeta 
potentials of micelles and micellar complexes are tabulated in Table 3.2. The sizes of 
the micelles and micellar complexes were approximately less than 200 nm, which not 
only made them escape from renal exclusion and reticulo-endothelial system 
elimination, but also gave them enhanced vascular permeability. Observed from DLS 
measurements, the sizes of the micelles increased as the PNIPAAm blocks become 
longer. The sizes of the micellar complexes were more than the sizes of the micelles 
due to the self-assembly of MPEG-PDMAEMA on the surfaces of the micelles. The 
zeta potential of micelle was below -10 mV. The negative charge caused by gelatin was 
screened by the diblock copolymers in the micellar complex. The zeta potential of the 
micellar complex was measured to be around 0 mV because of MPEG blocks on the 
surface of the micellar complexes. 
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Table 3.2. Particle sizes and zeta potentials of micelles and micellar complexes 
 a Micelle was prepared form PNIPAAm-grafted gelatin. Micelle was denoted by NGx. The 
number of the micelle is x.  
 b Micellar complex was prepared from PNIPAAm-grafted gelatin and MPEG-PDMAEMA. 
Micellar complex was denoted by NGEDx. The number of micellar complex is x.   
The morphologies of the micelles and micellar complexes were investigated by 
TEM observation, as shown in Figure 3.4. The structures of micelles and micellar 
complexes were identified by the staining of the dried micelles and micellar complexes 
[34]. Figure 3.4 shows the spherical structures of micelles and micellar complexes. The 
integrity of the structure was demonstrated. The size obtained from DLS measurement 
is more than the size obtained with image analysis of TEM micrographs. For instance, 
the Z-average diameter of the NGED1 micellar complex was 105.3 nm which was 
obtained from the result of DLS measurement. However, TEM micrographs show that 
the diameter of the micellar complex is about 80 nm. The difference is due to the 
sample preparation method [34]. The particle size was obtained from DLS 
measurement while micellar complexes were in water. The aqueous micelle solution 
was dried on copper grids for TEM observation. Drying resulted in the shrinking of the 
dehydrated micelles and micellar complex. 






NG1 NGG1 100.9 0.032 -12.9
NG2 NGG2 107.6 0.052 -13.6
NG3 NGG3 118.5 0.139 -10.8
Micellar
complexes b
NGED1 NGG1 and MPEG-PDMAEMA 105.3 0.066 -1.56
NGED2 NGG2 and MPEG-PDMAEMA 127.2 0.063 -1.38
NGED3 NGG3 and MPEG-PDMAEMA 134.4 0.062 0.594
 




Figure 3.4. (a) TEM micrographs of NG1 micelles and NGED1 micellar complexes. (Scale bar: 
100 nm) (b) Particle size distributions of NG1 micelle and NGED1 micellar complexe 
(Concentration: 0.1 mg/mL). 
3.3.5 Stability  
The drug carriers which possess highly electronic charges and hydrophobic 
groups maybe rapidly removed from the blood by macrophages after systemic 
administration [35]. The use of hydrophilic polymer chains, such as PEG, bound to the 
nanoparticle surface can prevent uptake by the mononuclear phagocytic system [36].  
The stability of micellar complexes was tested in the presence of FBS. For in 
vivo application, low interaction with blood components is important for polymeric 
micelles to slow down rapid uptake by the macrophages. In vitro cytotoxicity studies 
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micellar complex was studied in the presence of FBS through analysis of particle size 
ratio. Figure 3.5 shows the stabilities of micelles and micellar complexes in the 
presence of FBS at physiological conditions (pH 7.4, 37 °C).  It was observed that 
micellar complexes were relatively stable after 12 h. However, the size ratio of micelles 
changed significantly in less than 2 h. The stability of micellar complexes in serum is 
likely to be attributed to their highly hydrophilic surface. The hydrophilic MPEG 
corona of micellar complex protects them from non-specific adsorption of serum 
components to reduce the aggregation or destabilization induced by serum proteins. 
 
Figure 3.5. Evaluation of the size changes of NG2 micelles and NGED2 micellar complexes in 
PBS buffer that contains 20% (v/v) FBS at 37 °C, as determined by DLS. Data are shown as 
mean ± SD (n=3). 
3.3.6 Degradation 
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the presence of collagenase. After the peptide bonds in gelatin were broken by 
collagenase, the structure of micelle was destroyed. The ratio of particle size indicates 
the stability of micelles. The particle size ratio of the micellar complex was below 1.33 
at 20 h and it of the micelle was near to 3 at 3 h (Figure 3.6). It was due to the exposure 
of gelatin to collagenase. The hydrophilic surface of micellar complex protected gelatin 
from degradation by collagenase. 
 
Figure 3.6. Evaluation of the size changes of micelles and micellar complexes in PBS buffer 
containing collagenase at 37 °C, as determined by DLS. Data are shown as mean ± SD (n=3). 
3.3.7 Drug Loading and Release 
The drug encapsulation properties and release characteristics were affected by 
the size and morphology of the micelles and the micellar complexes. The lengths of 
PNIPAAm were correlated to the particle sizes in the micelles and micellar complexes. 
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increase of graft copolymer (Table 3.3). PNIPAAm core became more hydrophobic to 
stabilize MTX while the length of PNIPAAm was increased [37]. MPEG-PDMAEMA 
on the surface of the micelle inhibited the MTX diffusion out of the hydrophobic core, 
which resulted in high loading efficiency.  
Table 3.3. Loading efficiencies and loading levels of micelles and micellar complexes  
 
The in-vitro release kinetics of MTX from micelles or micellar complexes at 
37 °C was studied in PBS buffer (pH 7.4) and compared with it of MTX from micellar 
complexes at 25 °C. MTX released from the micelles or micellar complexes was 
isolated from the micellar solution using dialysis membrane. Figure 3.7 shows the 
percentage of MTX release from the micelles and micellar complexes at different 
temperatures. The NG1 micelles exhibited an initial burst release 37% of MTX at 37 °C 
in the initial 10 h (Figure 3.7a). The core encapsulating MTX became compact when 
the length of PNIPAAm block in the copolymer was increased. The slow diffusion of 
MTX in hydrophobic core resulted in the slow drug release. The MTX release from 
NG3 micelle was slower than others (Figure 3.7b). Less MTX was released from 
micellar complexes in the burst release stage, because the MPEG-PDMAEMA shell 
inhibits the diffusion of MTX. About 31% of MTX was released from NGED1 micellar 
complexes within 22 h. The release behavior of micellar complexes was obviously 
Samples Loading efficiency (%) Loading level (%)
NG1 22.5 5.5 
NGED1 29.1 3.3 
NG2 23.3 5.5 
NGED2 38.4 4.3 
NG3 25.9 6.0 
NGED3 43.2 4.6 
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divided into a burst release in the first period and a sustained release over a prolonged 
time [38]. 43% of MTX was released from NGED1 micellar complex while 88% of 
MTX was released from NG1 micelle within 166 h. The sustained release is desirable to 
a therapeutic concentration and it can maintain the therapeutic concentration by 
compensating for metabolic loss [39]. NGED3 micellar complex released the majority 
(89%) of its content at 25 °C within 22 h, but it only released 13% of its content at 37 °C 
within 22 h. The MTX release behaviors of micellar complexes indicated that the 






























Figure 3.7. (a) Release profiles of MTX from micelles and micellar complexes. (b) Release 
profiles of MTX from NG3 micelles and NGED3 micellar complexes at 37 °C in comparison 
with it from NGED3 micellar complexes at 25 °C. Data are shown as mean ± SD (n=3). 
3.3.8 Internalization 
Confocal laser scanning microscopy (CLSM) is an important cellular analysis 
technique which has been used with considerable success in the real-time observation 
of cells [40]. The cellular uptake behavior of micellar complexes was observed in 
Hela cells by CLSM in this work. Figure 3.8 shows the representative pictures of Hela 
cells incubated with FITC-labeled micellar complexes for 4 h and stained with DAPI. 
The green fluorescence from FITC and the blue fluorescence from DAPI were 
detected in the intracellular compartment. After incubation of Hela cells with 
FITC-labeled micellar complexes, the fluorescence become more concentrated from 1 
to 4 h in the cytoplasm where FITC molecules were located (Figure 3.8a). The 
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inside the cells with time (Figure 3.8b & 3.9).  
The intracellular distribution of FITC on micellar complexes was the direct 
evidence of the accumulation of micellar complexes in cytoplasm, suggesting that 
micellar complexes can be internalized into Hela cells. 
 
Figure 3.8. Confocal images of Hela cells incubated with DAPI and FITC-labeled micellar 
complex to observe its distribution. (a) FITC-labeled micellar complex (0.1 mg mL-1) treated 
with Hela cells at 4 h. (b) Superimposed images of FITC and DAPI encapsulated by Hela cells. 
The scale bar is 20 μm. (Green fluorescence is associated with FITC, and blue fluorescence is 








Figure 3.9. FITC fluorescence intensities of Hela cells incubated with samples to observe the 
distribution of FITC-labeled micellar complex at different incubation times. Data are shown as 
mean ± SD (n=50). 
3.3.9 Cytotoxicity Evaluation  
The cytotoxicity of the graft copolymer and diblock copolymer was evaluated 
by simulating clinical conditions in vitro [41]. L929 cells were incubated with the 
copolymer solution for 24 h at 37 ˚C in a humidified 5% CO2 atmosphere. The potential 
toxicological hazard was determined using MTT assay. The cell viability was always 
above 95%, while the concentration of the copolymer was below 15.6 mg/L (Figure 
3.10). Therefore, the low cytotoxicity of the graft copolymer and diblock copolymer 




































Figure 3.10. Cell viability incubated with known concentrations of PNIPAAm-grafted gelatin 
and MPEG-PDMAEMA copolymer. Data are shown as mean ± SD (n=3). 
3.4 Conclusions 
PNIPAAm-grafted gelatin and MPEG-PDMAEMA were successfully 
synthesized by ARGET ATRP. The micellar complex from PNIPAAm-grafted gelatin 
and MPEG-PDMAEMA was prepared using dialysis method. DLS data and TEM 
images revealed that micellar complexes are spherical in shape and above 110 nm in 
size. Results concerning degradation, stability and cytotoxicity indicate that the inner 
component of PNIPAAm-grafted gelatin was protected by the hydrophilic PEG 
corona. The correlation between the drug release and the length of PNIPAAm was 
studied for the micelles and micellar complexes. Thermosensitive and sustained drug 
release was obtained with incorporating PNIPAAm into gelatin-based biomaterials 
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experiment exhibited that FITC-labeled micellar complexes could be internalized into 
cancer cells. The results of the cytotoxicity tests demonstrated that the graft and block 
copolymers were noncytotoxic. We anticipate that the aforementioned micellar 
complex can be used for therapeutic application in drug delivery.   
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CHAPTER 4 BIODEGRADABLE GELATIN-BASED 
HYDROGELS WITH β-CYCLODEXTRIN AS 
CROSSLINKER AS WELL AS BINDING SITE FOR 
ENHANCED DRUG LOADING AND CONTROLLED 
RELEASE 
4.1 Introduction 
Hydrogels are chemically or physically crosslinked polymeric networks that 
can retain large amount of water in their three dimensional structures [1, 2]. Gelatin is 
the denatured form of animal-derived collagen. It has been extensively used for 
industrial, pharmaceutical, and medical purposes due to its excellent biodegradability 
[3], biocompatibility [4], and gel-forming ability [5]. Gelatin can be chemically 
crosslinked to form hydrogels for relatively long-term biomedical applications [6]. 
Different types of crosslinking agents, such as GTA [7], carbodiimide [8], dextran 
dialdehyde [9], and genipin [10, 11] were used to create chemically crosslinked 
gelatin-based hydrogel for various biomedical applications such as drug delivery and 
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tissue engineering. The physicochemical properties of gelatin-based hydrogels can be 
modulated by GTA, and stable hydrogels can be obtained, but its application was 
limited due to the toxicity of GTA [12]. Genipin as crosslinking agent shows 
remarkably less cytotoxicity than GTA [13], so genipin-crosslinked gelatin materials 
were widely studied recently [14-17]. 
Cyclodextrins (CDs) are a series of natural cyclic oligosaccharides with 
different numbers of glucose units [18-21]. The most abundant CDs are α-, β-, and 
γ-CD composed of 6, 7, or 8 D(+)-glucose units linked by α-1,4-linkages, respectively. 
Hydroxyl groups of CDs can be modified for introducing various functional groups 
onto the macrocyclic rings. Therefore, a large number of reactive and functional 
groups in the CD derivatives can be exploited to prepare covalently crosslinked 
networks [22, 23]. Covalent attachment of CDs to chemically crosslinked networks 
may enable CDs to fully display their complexation capabilities, while preventing the 
dilution phenomenon [23]. It has been demonstrated that β-CD can form an 1:1 
inclusion complex with MTX molecule via its empty molecular cavity, which can 
improve the solubility of the drug in aqueous hydrogel environment [24]. Additionally, 
CDs are attractive natural molecules with favorable toxicological profile for various 
types of drug delivery systems due to its ability of partly or completely hosting active 
molecules to protect them from the external environment [25]. 
A shortcoming of the injected anticancer drugs is to kill healthy tissues and have 
short in vivo distribution half-lives [26]. Much interest has been focused on hydrogels 
for localized delivery of anticancer drugs. MTX has been incorporated into crosslinked 
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oxidized alginate hydrogels without CD and the release period was extended with 
increasing the crosslinker content [27]. Hydrogels functionalized with β-CD have been 
prepared by using free radical crosslinking or photocrosslinking, and used as drug 
carriers which can increase the solubility of drug and retard its diffusion in aqueous 
environment [28, 29]. However, there has been no report on biodegradable 
gelatin-based hydrogels chemically crosslinked and functionalized by β-CD for 
anticancer drug delivery.  
In this work, we demonstrate a simple and practical method to prepare 
chemically crosslinked gelatin-based hydrogels using β-CD as the crosslinking agent as 
well as host molecule for enhanced binding of MTX, to achieve relatively high drug 
loading level as well as controlled and sustained release of the anticancer drug. Herein, 
β-CD was activated by 1,1’-carbonyldiimidazole (CDI) to form a reactive β-CD 
crosslinker, which subsequently was allowed to crosslink gelatin at room temperature 
to give hydrogels. The anticancer drug MTX was loaded into the hydrogels. Our data 
showed that the formation of β-CD/MTX inclusion complex within the hydrogels could 
increase the MTX loading level and also enhance the property of the hydrogels for 
controlled and sustained release of the loaded MTX. From the MTT assay results of the 
copolymers, the gelatin-based hydrogel is expected to be safe for biomedical 
applications. 
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4.2 Experimental Sections 
4.2.1 Materials 
Gelatin from porcine skin (type A, 300 g bloom), collagenase 
(clostridiopeptidase A, type VII), CDI, dextran (Mr 1,500), MTX, and MTT were 
obtained from Sigma-Aldrich (Singapore) and were used as received. -CD and pyrene 
were supplied by Fluka. All other reagents were purchased from Sigma-Aldrich 
(Singapore) unless otherwise stated. 
4.2.2 Synthesis and Characterization of Gelatin-based Hydrogels 
CDI and -CD (5:1, w/w) were placed in two three-necked flasks respectively 
and dried by vacuum overnight. 25 mL anhydrous DMF was added to each flask under 
N2 atmosphere. The -CD solution was transferred to a funnel and added dropwise into 
the CDI solution at the rate of 3 - 4 seconds per drop under atmosphere. The reaction 
was carried out at 24 °C for 24 h under N2 atmosphere. The crude product obtained was 
precipitated from 1 L mixed solvent of THF and diethyl ether (1:3, v/v) and centrifuged. 
The precipitate was dissolved in 5 mL PBS buffer for crosslinking reaction.The PBS 
buffer had a pH of 7.4±0.2, and 137 mM of NaCl, 2.7 mM of KCl, and 10 mM of 
phosphate. Gelatin (1.5 g) was dissolved in 15 mL of PBS buffer at 37 °C. The 
crosslinker solution was mixed with gelatin solution as quickly as possible. The 
mixture solution was ultrasonicated for 5 min at 24 °C. The reaction mixture (10 mL) 
was dropped into a plastic petridish (i.d. 85 mm). The crosslinking reaction was carried 
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out for 3 days at 24 °C. The resultant gelatin-based hydrogels were rinsed with ddH2O 
and kept in ddH2O containing 0.1 wt% NaN3 (for preventing the growth of bacteria) for 
3 days to extract out unreacted reactants and/or byproducts. Water was changed every 
12 hrs. The hydrogels were dried in air and lyophilized successively. The dry hydrogels 
were stored in a dry cabinet before characterization and testing. For comparison, a 
gelatin-based hydrogel was also prepared using dextran instead of -CD as the 
crosslinker following the same procedures. 
The contents of -CD in dry hydrogels were determined by 1H NMR 
spectroscopy with sodium 3-trimethylsilyl-1-propanesulfonic (TMS) as external 
standard in D2O. The gelatin-based hydrogel samples were treated with NaOH solution 
(0.5 M) and lyophilized before the NMR measurements. The contents of -CD in the 
hydrogel samples were calculated from comparing the integrals of C(1)H of -CD and 
-CH3 of TMS. 
The crosslinking degree of the gelatin-based hydrogels was determined using 
2,4,6-Trinitrobenzene sulfonic acid (TNBS) assay. The un-reacted primary -amino 
groups of lysine in gelatin could react with TNBS, and the TNBS-labeled amino groups 
could be detected by UV absorption using a UV-vis spectrophotometer (UV-2450, 
SHIMADZU) [30, 31]. Then the crosslinking degree could be obtained from the 
differences between the absorbance values before and after crosslinking using the 
following equation: 
Crosslinking degree = (1 – A/A0) x 100%                        (4.1) 
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where A is the absorbance of the crosslinked hydrogel sample, A0 is the 
absorbance of the un-crosslinked gelatin.  
Fourier transform infrared (FTIR) spectra of materials and gelatin-based 
hydrogel were recorded on a Bio-Rad 165 FT-IR spectrophotometer from discs 
containing sample in potassium bromide (KBr); 64 scans were signal-averaged with a 
resolution of 2 cm-1 at 24 °C. 
4.2.3 Swelling Properties of Gelatin-based Hydrogels 
Swelling behavior was studied by the general gravimetric method. Hydrogel 
samples (around 5 mg each) were immersed in PBS buffer at 24 °C, and the swollen 
hydrogels were measured at predetermined time points until they reached equilibrium. 
At predetermined time points, the swollen hydrogels were drawn from the solution, 
wiped with filter paper to remove excess liquid, and weighed. Extreme care was taken 
to preserve the integrity of the hydrogels in the process. The swelling ratio is the 
weight ratio of retained water and dry hydrogels. The swelling ratio can be then 
calculated by the following equation:  
Swelling ratio = [(Ws - Wd)/Wd] × 100%                           (4.2) 
where Ws is the weight of the swollen hydrogel and Wd is the weight of dry 
hydrogel. 
4.2.4 Degradation  
A series of gelatin-based hydrogels of approximate 10 mg, which were firstly 
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fully swollen in PBS buffer, were placed in 2.5 mL of PBS buffer with 20 units/mL of 
collagenase and 0.36 mM of CaCl2, and incubated at 37 °C [31]. Sodium azide (NaN3) 
(0.1 wt%) was added to prevent growth of bacteria. At various time intervals, the 
remained gelatin-based hydrogel samples were taken out and the weight was measured 
after lyophilization. The remained weight ratio is given by the following equation: 
Remained weight ratio = (Wt/W0) x 100%                         (4.3) 
where Wt is the weight of dry hydrogel at time t, and W0 is the original weight of 
the dry hydrogel before degradation.  
4.2.5 Binding of Pyrene with β-CD  
Pyrene was used as a hydrophobic fluorescent probe [32, 33]. Fluorescence 
spectra were recorded on a Shimadzu RF-5301PC spectrofluorophotometer. For 
measuring fluorescence spectra of pyrene at the absence and presence of β-CD in 
aqueous solution, samples were prepared by dissolving a predetermined amount of 
β-CD in an aqueous pyrene solution, and the solutions were allowed to stand for 1 day 
for equilibration. The concentration of pyrene was kept at 6.0 x10-7 M. 
For binding of pyrene with β-CD in hydrogels, a pyrene stock solution was 
prepared as follows. Pyrene dissolved in methanol (0.3 mL, 2×10-4 M) was added into a 
flask, and methanol was evaporated by N2 gas, followed by adding 100 mL ddH2O to 
obtain the pyrene aqueous solution with a concentration of 6×10-7 M. After being 
swollen in PBS buffer for one day, a gelatin-based hydrogel sample was immersed in 2 
mL of the pyrene stock solution so that pyrene could enter into the hydrogel. Emission 
Chapter 4 Biodegradable Gelatin-based Hydrogels with β-cyclodextrin (β-CD) as Crosslinker as well as Binding 
Site for Enhanced Drug Loading and Controlled Release 
109 
 
spectra were recorded at the range from 350 to 450 nm with an excitation at 337 nm. 
Both excitation and emission bandwidths were 5 nm. From the pyrene emission spectra, 
the intensities of the first band (I) at 373 nm and the third band (III) at 384 nm, and the 
ratio (indicated as III/I) between them were analyzed for gelatin-based hydrogels 
containing different crosslinkersand various CD contents. 
4.2.6 Binding of MTX with β-CD 
For investigating the binding of MTX with free β-CD in aqueous solution, the 
absorption spectra of MTX (10 μM) in PBS buffer at the absence and presence of β-CD 
were recorded [24]. 
For investigating the binding of MTX with β-CD in hydrogels, MTX was 
loaded into hydrogels as follows. After being swollen in PBS bufferfor one day, a 
gelatin-based hydrogel sample was immersed in 2 mL of MTX saturated PBS solution 
for 24 hours. MTX adsorbing on the hydrogel surface was washed away with PBS 
buffer. The UV-vis spectra of the MTX loaded hydrogels were recorded at 24 °C. 
4.2.7 MTX Drug Loading and Release 
MTX was loaded into the hydrogels by immersing the hydrogel samples in 
MTX saturated PBS buffer. Briefly, after being swollen in PBS for one day, the 
gelatin-based hydrogel samples (c.a. 10 mg each) were immersed in 2 mL of MTX 
saturated PBS buffer in a centrifuge tubes for 24 h. The hydrogel samples were washed 
with ddH2O three times to remove the adsorbed MTX on the surface of the samples. 
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The amounts of the loaded MTX in the hydrogel samples were determined by UV-vis 
absorption at 372 nm after the crosslinked hydrogels were degraded enzymatically. The 
MTX drug loading levels (mg/g hydrogel) can be obtained by the following equation: 
 Drug loading level = WMTX/Wgel                              (4.4) 
where WMTX is the weight of loaded MTX in mg, and Wgel is the weight of the 
dry hydrogel. 
For MTX release, the MTX loaded gelatin-based hydrogels were immersed in 5 
mL of PBS buffer and incubated at 37 °C. Aliquots of the PBS buffer (1 mL) were taken 
at predetermined time points and the same values of PBS buffer were returned. The 
MTX concentrations in the aliquots of the PBS buffer were determined by UV-vis 
absorption at 372 nm. The experiments were carried out in triplicate. 
4.2.8 Cytotoxicity Evaluation 
MTT assay was used to evaluate the biocompatibility of extracts of the 
crosslinked hydrogels [34]. The in vitro cytotoxicity tests were performed in a 96-well 
cell culture plate. L929 mouse fibroblasts were obtained from ATCC and cultivated in 
DMEM containing 10% FBS and 1% PS. The cells were resuspended in 
serum-supplemented DMEM at a concentration of 1×105 cells mL-1. Cells were 
cultured at 37 ˚C and 5% CO2.  
0.05 g dried hydrogel was immersed in 1 mL DMEM for 24 h at 37 ˚C after UV 
sterilization for 30 min. The medium, containing the extracts from crosslinked hydrogel, 
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was diluted with fresh DMEM. Culture medium for L929 cells after 24 h was 
exchanged with the extract medium. Fresh medium and phenol solution in DMEM (2 
mg/mL) were used as negative control and positive control. The plates were incubated 
at 37 ˚C and 5% CO2 for another 24 hours. 10 L of MTT solution (5 mg/mL) was 
added to each well. After 4 h of incubation, MTT solution was removed and 100 L of 
DMSO was used to dissolve the insoluble formazan crystals. The absorbance of the 
formazan product was measured at 570 nm using a microplate reader (FLUOstar 
OPTIMA, Labtech). Cell viability was normalized with the results from the negative 
control samples. 
4.3 Results and Discussion 
4.3.1 Synthesis and Molecular Characterization of Gelatin-based Hydrogels 
The synthesis procedure involved the activation of the hydroxyl groups of 
β-CD and the coupling reaction betweenthe activated β-CD and gelatin (Scheme 4.1). 
The primary hydroxyl groups of -CD molecules could be activated by CDI [35-39], 
and the activated -CD crosslinker was allowed to react with the amino group (–NH2) 
of gelatin to give the chemically crosslinked gelatin-based hydrogels. The 
crosslinking reaction was conducted under aqueous condition. Although CDI is 
moisture sensitive and will lose reactivity by reacting with H2O to form imidazoles 
and CO2, the carbanate intermediate is not as sensitive to water as CDI does. The 
crosslinking reaction of gelatin using the CDI-activated -CD carried out efficiently 
in water at room temperature. Gelatin-based hydrogels with different -CD contents 
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and crosslinking degrees were prepared (Table 4.1). For comparison, a gelatin-based 
hydrogel sample using dextran as crosslinker was also prepared (Dex-Gel in Table 4.1). 
The β-CD content and crosslinking degree both increased with an increase in the 
amount of β-CD used in the hydrogel synthesis. The β-CD content increased from 11.1% 
for -CD-Gel-1, to 13.5% for -CD-Gel-2, and 15.2% for -CD-Gel-3. The 
crosslinking degree increased from 21.3% for -CD-Gel-1, to 24.3% for -CD-Gel-2, 
and 36.5% for -CD-Gel-3, while Dex-Gel had a crosslinking degree of 26.4%.  
Table 4.1. Synthesis conditions, yields, β-CD contents, and crosslinking degrees of 
gelatin-based hydrogel samples 
 
 a β-CD-Gel-n denotes gelatin-based hydrogels crosslinked by β-CD crosslinker, and the number n is 
the sample number. Dex-Gel denotes gelatin-based hydrogel crosslinked by dextran crosslinker.  
 b The weight of the hydrogel obtained after drying. 
 c Weight ratio of β-CD in hydrogel calculated from 1H NMR data with TMS as external standard in 
D2O.  





Gelatin (g) β-CD or
dextran (g)




β-CD-Gel-1 1.50 0.20 1.31 11.1 21.3
β-CD-Gel-2 1.50 0.30 1.44 13.5 24.3
β-CD-Gel-3 1.50 0.50 1.45 15.2 36.5
Dex-Gel 1.50 0.30 1.33 0 26.4
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Scheme 4.1. Schematic illustration for the synthesis of the gelatin-based hydrogel with β-CD 
crosslinker and the MTX loading into the hydrogel enhanced by the inclusion complexation 
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Figure 4.1 shows the FTIR spectra of -CD, gelatin, and gelatin-based hydrogel. 
In the FTIR spectrum of β-CD (Figure 4.1a), the broad band with the peak at 3371 cm-1 
is assigned to the symmetric and antisymmetric OH stretching modes for pure -CD. 
The peaks at 1150, 1070, and 1028 cm-1 in Figure 1a are assigned to CO stretching 
vibration of glucosidic bonds, CO stretching vibration in cyclic alcohols, and CO 
stretching vibration in primary alcohols, respectively [40-42]. In the FTIR spectrum of 
gelatin (Figure 4.1b), typical characteristic bands of amide I and II for gelatin can be 
observed. Amide I band mainly due to C=O stretching vibration of the amide group 
coupled with in-plane NH bending (1700-1600 cm-1) is most widely used in studies of 
protein secondary structure. Amide II (1580-1480 cm-1) is assigned to in-plane NH 
bending and CN stretching vibration. Other amide vibrational bands have less practical 
use in protein conformational studies [43, 44]. The spectrum of -CD-Gel-2 (Figure 
4.1c) is characterized by the presence of the typical vibration peaks and bands of its two 
main components -CD and gelatin, indicating that -CD was integrated with gelatin 
successfully. 
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4.3.2 Swelling Analysis  
The swelling ratio of a hydrogel is important in various applications since it 
affects surface properties, mechanical properties, and the diffusion of solutes [45]. 
The swelling ratio is dependent on the interaction between the solvent and the 
polymer, and the pore size of the polymer networks [46]. Figure 4.2 shows the 
swelling of the gelatin-based hydrogels at different time points. All the gelatin-based 
hydrogels could swell in PBS buffer up to 200 – 900%. For -CD-crosslinked 
gelatin-based hydrogels, higher crosslinking degrees resulted in lower swelling ratios. 
The swelling ability decreases from 492% for -CD-Gel-1 to 275% for -CD-Gel-3 
due to the increase of the crosslinking degree. However, the swelling ratio for Dex-Gel 
was much higher than all -CD-crosslinked gelatin-based hydrogels, probably due to 
the different conformation and also the high water-solubility of dextran. 
 
Figure 4.2. Swelling ratio of the gelatin-based hydrogels in PBS buffer at 24 °C as a function of 
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4.3.3 In vitro Degradation Behavior of Gelatin-based Hydrogels 
One of the disadvantages for many gelatin-based biomaterials is the fast 
degradation in vivo. Probably, crosslinking is the most effective method to solve this 
problem. However, since gelatin-based hydrogels undergo enzymatic hydrolysis in the 
body, it is too difficult to evaluate their degradation profile under in vitro conditions 
without any enzymes. Some groups have reported studies on enzymatic degradation of 
collagen and gelatin-based materials [47-50]. In this work, we investigated the in vitro 
enzymatic degradation of our synthesized gelatin-based hydrogels, and also studied the 
relationship of the degradation rate with the crosslinking degree and swelling ratio of 
these hydrogels 
Figure 4.3 shows the weight loss of the gelatin-based hydrogels as a function of 
degradation time. In the presence of collagenase, the enzyme diffused inwards to 
degrade the gelatin-based hydrogels [51]. For β-CD-crosslinked hydrogels, the 
degradation rate decreased with an increase in crosslinking degree of the hydrogel 
samples. This result indicates that the higher crosslinking degree of the gelatin-based 
hydrogels caused more resistance to degradation in collagenase solution in PBS buffer 
[8]. It is thought that the crosslinking could limit the accessibility of enzyme to the 
cleavage sites of the hydrogels, and to prevent the penetration of the enzymes into the 
bulk of the material. As a result, -CD-Gel-3 had the lowest degradation rate among 
these four gelatin-basedhydrogels. It only had weight loss of 40% up to 80 minutes 
degradation. In contrast, -CD-Gel-1 degraded almost completely within one hour. 
However, Dex-Gel, whose crosslinking degree (26.4%) is similar to that of -CD-Gel-2 
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(24.3%), degraded the fastest, even faster than -CD-Gel-1 with lower crosslinking 
degree (21.3%). This may be caused by the high swelling ratio of Dex-Gel (Figure 4.2). 
Eventually, the trends for the swelling ratio and degradation rate are very similar for all 
the four gelatin-based hydrogels, regardless they are crosslinked by -CD or dextran. 
From Figures 4.2 and 4.3, both the swelling ratio and degradation rate follow the 
sequence: Dex-Gel >-CD-Gel-1 >-CD-Gel-2 >-CD-Gel-3. Therefore, the higher 
the water content of the hydrogels, the faster they degrade [48]. 
 
Figure 4.3. Enzymatic degradation of gelatin-based hydrogels in PBS buffer containing enzyme 
at 37 °C and pH 7.4. Data are shown as mean ± SD (n=3). 
4.3.4 Binding of Pyrene with β-CD in Solution and in Hydrogels 
Gelatin-based hydrogel is totally hydrophilic because of its peptide-based 
structure. After β-CD was introduced, the entire polarity of the hydrogel and its 
micro-environment are changed due to the hydrophobic inner cavity of β-CD. In order 
to monitor the changesof the polarity and micro-environment of the gelatin-based 
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micro-environment of the gelatin-based hydrogels. Pyrene is one of the most 
commonly used polarity-sensitive probes which can form inclusion complex with β-CD 
[33]. The π*π emission spectrum of monomer pyrene exhibits five well-resolved 
major vibronic bands between 370 and 400 nm, generally labeled I, II, III, IV and V, in 
progressive order. Due to coupling of the electronic and vibronic states, the first 
vibronic band undergoes significant intensity enhancement with increasing polarity 
compared to the third band. Consequently, the ratio of emission intensities of the 
vibronic bands III and I can be used as the indicator to indicate the relative polarity of 
the environment [52, 53]. On the other hand, pyrene can form inclusion complex with 
CDs except -CD, since the size of -CD is too small to include pyrene molecule [54]. 
The resultant fluorescence spectrum of CD-complexed pyrene is greatly different from 
that of free pyrene in aqueous solution. 
Figure 4.4a shows the fluorescence spectra of pyrene in aqueous solution at the 
absence and presence of -CD. The pyrene concentration was 6×10-7 M. In the presence 
of -CD, the emission intensity was higher than that of pyrene in pure water. 
Fluorescence enhancement was probably due to the improved solubility of pyrene that 
may be adsorbed to the walls of the container. Besides, the III/I ratio (which stands for 
the ratio of third and first vibronic bands of pyrene fluorescence intensities) changed 
from 0.62 to 1.04. The change of III/I ratio indicates that pyrene has entered into the 
inner hydrophobic cavity of -CD to form inclusion complex. It can be anticipated that 
the similar phenomena can be observed after pyrene is adsorbed into the gelatin-based 
hydrogels, if -CD has been introduced into the hydrogels successfully.  
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The gelatin-based hydrogels were fully swollen in PBS first before the 
adsorption of pyrene was carried out by immersing the swollen gelatin-based hydrogel 
samples in pyrene aqueous solution (6×10-7 M). The fluorescence spectra of pyrene in 
the different gelatin-based hydrogels were shown in Figure 4.4b. The III/I ratios in 
various gelatin-based hydrogels were 1.36 for β-CD-Gel-1, 1.44 for β-CD-Gel-2, and 
1.46 for β-CD-Gel-3. All of the three -CD-crosslinked gelatin-based hydrogels had 
much higher III/I ratios than that of pyrene in pure water (0.62), indicating that the 
pyrene molecules were adsorbed into the hydrogels and included within the 
hydrophobic β-CD cavities in the hydrogels. The fluorescence intensity for Dex-Gel 
treated the same way with pyrene aqueous solution was very low, making it impossible 
to calculate the III/I ratio. Dex-Gel was crosslinked with dextran and lacked of β-CD 
units as binding sites. Almost no hydrophobic pyrene molecules could be adsorbed into 
Dex-Gel. Although the β-CD-crosslinked gelatin-based hydrogels are hydrophilic in 
bulk, the hydrophobic cavities of the β-CD crosslinkers changed the 
micro-environment of the hydrogels, providing binding sites for including and 
complexing hydrophobic pyrene, which enhanced the adsorption and loading of pyrene 
into the β-CD-crosslinked gelatin-based hydrogels. From Figure 4.4b, generally the 
fluorescence intensity of pyrene in hydrogels followed the trend 
β-CD-Gel-3 >β-CD-Gel-2 >β-CD-Gel-1 >>Dex-Gel. Here the fluorescence intensity 
can be considered to correlate the pyrene concentration or loading level in the 
hydrogels. Therefore, the higher β-CD content in the gels resulted in the higher loading 
level of pyrene.  
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Figure 4.4. Fluorescence emission spectra of (a) pyrene aqueous solution (6×10-7 M) at the 
absence and presence of β-CD (1×10-3 M); and (b) gelatin-based hydrogels (c.a.8×8 mm2, 5 mg) 
treated with pyrene aqueous solution (6×10-7 M). 
4.3.5 Binding of MTX with β-CD in Solution and in Hydrogels 
MTX is an antimetabolite and antifolate drug which is used in treatment of 
cancer, psoriasis, acute lymphoblastic leukemia, and so on. However, MTX has toxic 
side effects to normal cells, drug resistance, and leucopoenia and nephrotoxicity. 
Therefore, much research has been performed to reduce its adverse effects and 
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improve the specificity and selectivity [55]. MTX is known to form an inclusion 
complexwith β-CD to reduce adverse effects [24]. Herein, the ability of the β-CD 
crosslinkers in the gelatin-based hydrogels to act as binding sites to include and 
complex MTX was investigated. The UV-vis absorption spectra of MTX at the absence 
and presence of β-CD in PBS buffer were shown in Figure 4.5a. First, no absorption 
peaks were observed for pure β-CD PBS buffer solution. The absorption of MTX 
showed a peak with maximum at 372 nm. With the addition of β-CD up to 1000 µM, 
the absorbance of MTX increased gradually, and the maximum absorption wavelength 
shifted from 372 to 376 nm, indicating that the MTX molecules are included and 
complexed by β-CD.  
Figure 4.5b shows the UV-vis absorption spectra of β-CD-Gel-2 treated with or 
without MTX PBS solution. β-CD-Gel-2 without treatment of MTX solution showed 
no absorption peaks. β-CD-Gel-2 with treatment of MTX solution showed the 
absorption spectrum similar to that of the MTX solution, indicating that MTX 
molecules were loaded into the hydrogel. It was found that the maximum absorption 
peak wavelength of MTX in the hydrogel was 375 nm, compared to 372 nm for MTX 
aqueous solution. This indicates that the MTX molecules in the β-CD-Gel-2 hydrogel 
were included and complexed by the β-CD binding sites.  
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Figure 4.5. UV-vis absorption spectra of (a) MTX PBS buffer solution (10 µM) at the absence 
and presence of β-CD at various concentrations; and (b) β-CD-Gel-2 (c.a. 8×8 mm2, 5 mg) 
treated with or without MTX PBS solution (the spectrum of MTX solution is shown for 
comparison). 
4.3.6 MTX Drug Loading and Release 
MTX was selected as a model drug to evaluate the β-CD-crosslinked 
gelatin-based hydrogels in terms of their drug loading ability and controlled release 
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hydrogels. The loading level increased from 12.2 mg/g for β-CD-Gel-1, to 14.9 mg/g 
for β-CD-Gel-2 and 16.4 mg/g for β-CD-Gel-3. Obviously, the loading level increased 
with an increase in β-CD content and crosslinking degree for all three 
β-CD-crosslinked gelatin-based hydrogels. The enhanced loading ability of the 
hydrogels for MTX was due to the β-CD crosslinkers that could act as binding sites to 
include and complex MTX within the cavities of the β-CD crosslinkers. The β-CD 
crosslinkers eventually changed the micro-environment of the hydrogels. The 
complexation increased the solubility of MTX within the hydrophilic hydrogels, and 
provided a driving force for MTX molecules to diffuse in and be loaded within the 
hydrogels. 
As for Dex-Gel, although its crosslinking degree (26.4%) is similar to that of 
β-CD-Gel-2 (24.3%), the MTX drug loading level was much lower (7.8 mg/g) than that 
of β-CD-Gel-2 (14.9 mg/g), and even lower than that of β-CD-Gel-2 (12.2 mg/g) that 
only had a crosslinking degree of 21.3%. Obviously, the low MTX loading level of 
Dex-Gel was because that Dex-Gel was crosslinked by dextran instead of β-CD 
crosslinker. 
Figure 4.7 presents the in vitro drug release profiles for the different hydrogels 
loaded with MTX. Overall, Dex-Gel released all loaded MTX much faster than all three 
β-CD crosslinked hydrogels, and β-CD-Gel-1 released all its loaded MTX faster that 
β-CD-Gel-2, and followed by β-CD-Gel-3 that released the drug the slowest. For all 
four hydrogels, an initial burst release the loaded MTX from the hydrogels was 
observed within the first a few hours. This was mainly due to the un-complexed MTX 
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that diffused out from the hydrogels. The initial burst release ranged between 10 – 30% 
for β-CD crosslinked hydrogels, compared to that of about 75% for Dex-Gel. 
Apparently, inclusion complexation of MTX with β-CD retarded the diffusion of MTX 
from the hydrogels. It should be noted that the initial burst release of β-CD-Gel-1 was 
expected to be more than β-CD-Gel-2 and β-CD-Gel-3 due to its lowest β-CD content 
and crosslinking degree. However, the experimental data deviated from what was 
expected. One explanation is that much MTX loaded within the β-CD-Gel-1 hydrogel 
network was washed away during the purification steps due to its loose network 
structure (it had lowest crosslinking degree). Nevertheless, the overall release kinetics 
for β-CD-Gel-1 was faster than those of both β-CD-Gel-2 and β-CD-Gel-3, which is in 
consistent with that the inclusion complexation of MTX with β-CD could retard the 
diffusion of MTX and sustain the release of MTX from the hydrogels. 
After the initial burst release, the release rate decreased much for a certain 
period of time, and then the release rate was accelerated again until all loaded MTX was 
released. Particularly, the two hydrogels β-CD-Gel-2 and β-CD-Gel-3 more closely 
followed the unique multiphasic release profile. During the period of decreased release, 
it is thought that the MTX molecules were retarded by the strong binding of β-CD 
crosslinkers. The last phase where the release was accelerated may be due to the 
degradation of the hydrogels that caused dissolution of the hydrogel together with the 
drug. It was eventually observed that the hydrogel samples became much weaker and 
even broken into pieces during the last phase of the drug release.  
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Figure 4.6. MTX drug loading levels in different gelatin-based hydrogels. Data are shown as 
mean ± SD (n=3). 
 
 
Figure 4.7. Release profiles of MTX from gelatin-based hydrogels at 37 °C in PBS buffer (pH 
7.4) as a function of time. Data was shown as mean ± SD (n=3). 
4.3.7 Cytotoxicity Evaluation 
The cytotoxic response was quantified using the MTT assay. The extraction of 
crosslinked hydrogel was performed based on the ISO 10993 protocol. The extraction 
step simulates clinical conditions so as to evaluate the cytotoxicity of crosslinked 
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medium did not show significant cytotoxicity against L929 cells when the dilution ratio 
changed from 200% to 800%. The use of CDI and organic solvent increases a safety 
concern, particularly when they are cytotoxic chemicals. In this work, all cell viabilities 
of extract medium are above 90% (Figure 4.8). The MTT assay results indicate the 
non-cytotoxicity of the crosslinked hydrogels. 
 
Figure 4.8. Cell viability of L929 cells incubated with known concentrations of the aqueous 
extracts from gelatin-based hydrogels which were immersed in DMEM at 0.05 g/mL. The 100% 
concentration of phenol control was 2 mg/mL. Data was shown as mean±SD (n=3). 
4.4 Conclusions 
A series of new β-CD-crosslinked gelatin-based hydrogels (β-CD-Gel-1, 
β-CD-Gel-2, and β-CD-Gel-3), and a dextran-crosslinked gelatin-based hydrogel 
(Dex-Gel) as control compound, were synthesized and characterized. For β-CD-Gel-1, 
β-CD-Gel-2, and β-CD-Gel-3, the β-CD content was 11.1, 13.5, and 15.2%, and the 
crosslinking degree was 21.3, 24.3, and 36.5%, respectively, while the crosslinking 
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buffer up to 200 – 900%. The hydrogels degraded hydrolytically and the degradation 
was accelerated by collagenase in PBS buffer. Both the swelling ratio and degradation 
rate of the hydrogels followed the sequence: 
Dex-Gel >-CD-Gel-1 >-CD-Gel-2 >-CD-Gel-3. Therefore, the higher water 
content resulted in faster biodegradation of the hydrogels. 
Pyrene was used as a fluorescence probe to investigate the micro-environment 
of the gelatin-based hydrogels. Pyrene was adsorbed into the hydrogels by immersing 
the swollen hydrogel samples in pyrene aqueous solution. The fluorescence emission 
spectra of the pyrene-treated hydrogels showed that the three -CD-crosslinked 
hydrogels adsorbed much pyrene, and the III/I ratio of pyrene in the hydrogels was 1.36 
– 1.46, which was much higher than that of pyrene in pure water (0.62), indicating that 
the pyrene molecules in the hydrogels were included and complexed within the 
hydrophobic cavities of the β-CD crosslinkers in the hydrogels. Dex-Gel was 
crosslinked by dextran, and contained no binding site for pyrene. So, only trace of 
pyrene was found to be adsorbed in Dex-Gel. 
The anticancer drug MTX was used as a model drug, and the adsorption, 
loading, binding and complexation, and release of MTX in or from the hydrogels were 
investigated. MTX was adsorbed and loaded into the hydrogels by immersing the 
swollen hydrogel samples in MTX saturated aqueous solution. The loading of MTX in 
the hydrogels was confirmed by measuring the UV-vis spectra of the MTX-loaded 
hydrogels, the spectra indicated that the loaded MTX was complexed by β-CD in the 
β-CD-crosslinked hydrogels. The loading level was 7.8, 12.2, 14.9, and 16.4 mg/g for 
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Dex-Gel, β-CD-Gel-1, β-CD-Gel-2, and β-CD-Gel-3, respectively. The complexation 
of MTX with β-CD crosslinkers largely increased the loading level of MTX in the 
hydrogels. The complexation could also reduce the initial burst release effect, and then 
retard the release of the complexed MTX for a certain period, until the hydrogels started 
to hydrolytically degrade and all remained MTX was released. The above mentioned 
effects were particularly prominent for β-CD-Gel-3 that had highest β-CD content. Due 
to the unique structures and properties of the β-CD-crosslinked hydrogels, the 
hydrogels gave an interesting multiphasic profile for controlled and sustained release of 
MTX drug. From the MTT assay results of the extracts of the copolymer films and the 
determined tin content in the copolymer, the polymer is expected to be safe for 
biomedical applications. Thus, the β-CD-crosslinked gelatin-based hydrogels may be 
utilized as a promising drug carrier for controlled and localized delivery of hydrophobic 
anticancer drugs. 
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CHAPTER 5 MICROENCAPSULATION OF CELLS IN 
GELATIN-BASED MICROGELS FOR CELL DELIVERY 
5.1 Introduction 
A number of bioencapsulation technologies have been applied to protect tissues, 
cells, and biologically active compounds from potential hazardous processes in a 
physiological environment [1-3]. After Chang proposed microencapsulation as an 
alternative to creating artificial tissues and organs in 1960s [4], much attention has been 
attracted by the field of cells and bioactive compound immobilization. In such systems, 
cells are encapsulated by a permeable shell that allows exchange of O2, nutrients, and 
metabolites while it protects the inner cells from the host’s immune system [5]. It is 
important to provide an environment that mimics physiological conditions to maintain 
cellular functions. Cell delivery has been considered as the most promising approach 
while cells were cultured in matrix in 3-dimension environments [6-8]. Microgels 
(from 100 µm to 500 µm) can be implanted in vivo [9, 10]. It could be beneficial in 
some applications for the long-term functionality of encapsulated cells. Furthermore, 
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microgels can improve the permeability of oxygen and nutrients due to their large 
surface/volume ratio [11, 12].  
The simplest and most widely investigated approach is that alginate creates 
three dimensional structures when they react with multivalent ions. [13]. Alginates, 
naturally derived polysaccharides, are composed of (1-4)-linked β-D-mannuronic acid 
(M units) and α-L-guluronic acid (G units) monomers. The alginate molecule is a 
block copolymer composed of M-blocks, regions of G-blocks, and regions of 
atactically organized M and G units [14]. Alginate is inert because it lacks native 
ligands that could allow interaction with mammalian cells. Cations, such as Ca2+, bind 
between the G blocks of adjacent alginate chains, creating ionic interchain bridges 
which induce gelation of aqueous alginate solutions. Ionically crosslinked alginates 
lose mechanical stability over time in vitro, presumably due to an outward flux of 
crosslinking ions into the surrounding medium [15]. In addition, physical crosslinking 
results in poor mechanical stability of hydrogel, compared to chemical crosslinking 
[16]. 
Gelatin is a commonly used polymer derived from collagen. It forms 
biocompatible and biodegradable hydrogels due to its biocompatibility [17] and 
biodegradability [18] with minimal immunological responses. Gelatin hydrogel was 
used to act as the extracellular matrix (ECM) to support the whole structure for cell 
encapsulation [19, 20] since gelatin which is inexpensive can promote cell adhesion 
and proteolytic degradation [21]. Either UV-light or chemical crosslinker was used to 
create stable hydrogel [22]. Photocrosslinked hydrogel may encounter a limitation in 
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applications of deep tissue implants and its complex preparation process also limit its 
practical application [23]. Many of crosslinking agents often elicit either cytotoxic 
side-effects or immunological responses from the host [24, 25]. For example, after 
implantation of the material, polymeric chains crosslinked by GTA are hydrolysed and 
monomeric GTA is released into the tissue, resulting in cytotoxicity and inflammation 
[24]. 
In this work, we will report the gelatin-based microgel with soft gelatin core 
and permeable chitosan-alginate membrane has as an effective extracellular matrix for 
cell delivery. An easier method compared to the commonly used water-in-oil emulsion 
technique [26] was developed to prepare gelatin microgels. That is, a microgel core, 
composed of gelatin, alginate and crosslinker, was firstly prepared using an air-driven 
droplet generating method with calcium crosslinked alginate as template, after 
chemical crosslinking of gelatin and coating of chitosan/alginate, the alginate template 
inside the microgel core was removed with sodium citrate. 4-arm polyethylene glycol 
succinimidyl glutarate (pentaerytherital) (MW 10000) (sPEG-4A-GS(10k)) crosslinker 
was used to crosslink the gelatin in the microgel core because of its moderate 
crosslinking ability towards protein, non-cytotoxicity, and soft segments. The 
resultant microgel composed of a soft gelatin-based core and a permeable 
chitosan/alginate coating was fully characterized and the studies on the encapsulation 
of 3T3 cells in this gelatin-based microgel was carried out.  It was demonstrated that 
the gelatin-based microgel we developed is a suitable cell carrier for cell delivery. 
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5.2 Experimental Section 
5.2.1 Materials 
Type A gelatin from porcine skin (300 bloom), sodium alginate, Fluorescein 
isothiocyanate–dextrans (FITC-dextrans) (average molecular weight 4, 20, 40, and 70 
kDa), EDC, NHS, sodium citrate dihydrate were obtained from Sigma-Aldrich Pte Ltd. 
sPEG-4A-GS(10k) was purchased from JenKem Technology USA. The LIVE/DEAD 
reduced biohazard cell viability kit (Invotrogen L-7013) was ordered from Invitrogen. 
4-arm polyethylene glycol (MW 10000) (sPEG-4A(10k) was supplied by Shearwater 
Polymers. Chitsoan (Mn = 10 kDa) was provided by Haidebei Marline Bioengineering 
Co. Ltd., China. All other reagents were purchased from Sigma unless otherwise stated. 
5.2.2 Preparation and Characterization of Microgels 
The microgel preparation is schematically presented in Scheme 5.1. During 
the preparation of the gelatin-based microgels, an air-driven droplet generating 
method was adopted to gelatin cores according to the previously published method 
[27]. Microgels coated with chitosan and alginate were achieved according to the 
method described by Yu WT et al. [28]. Mixed solution of sodium alginate (2.5%, w/v) 
and gelatin (3%, w/v) were prepared by suspending gelatin in sodium alginate solution 
containing NaCl (0.9%, w/v) at 37 ºC. The solution (0.2 mL) with or without 
crosslinker was dispersed through a 1 mL syringe and blunt ended cut needle (27G, 
NIPRO, Osaka, Japan) connected to a nitrogen gas flow (300 L/h). The mixed solution 
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was sprayed into 10 mL CaCl2 solution (100 mM) in a 15-mL glass vial. After the 
microgels were incubated for 1 h at 37 ºC to complete gelatin crosslinking reaction 
(Scheme 5.2), the microgels were washed with NaCl solution (0.9%, w/v). The 
microgels were immersed into 10 mL chitosan solution (0.5%, w/v) for 10 min and 
washed with NaCl solution three times. The surface of microgel was further coated by 
incubating microgels in 10 mL sodium alginate solution (0.125%, w/v) for 10 min. The 
microgels were washed with NaCl solution. After liquidized for 10 min using 55 mM 
sodium citrate and rinsed with NaCl solution, microgels were ready for further use. The 
assembly of chitosan and alginate layers on the surface of microgels was monitored by 
a Zetasizer (Nano ZS, Malvern Instruments, Malvern, UK). Zeta potential 
measurements were carried out in triplicate. Microgels were observed with optical 
phase-contrast microscope (Olympus 1X51) after preparation. At least 100 microgels 
were randomly selected for sizing of microgels using software ImageJ.  
 
Scheme 5.1. Schematic illustration of preparation stages of gelatin-based microgels. 
 
 




Scheme 5.2. Type A gelatin and sPEG-4A-GS(10k) reaction. The succinimidyl groups react 
with the amine groups present on the molecules of gelatin at 37 ˚C. 
5.2.3 Investigation of the Properties of Crosslinked Gelatin/Alginate Hydrogel 
5.2.3.1 Quantification of Free Amines using TNBS Assay 
Gelatin and sodium alginate were dissolved in NaCl solution. 
sPEG-4A-GS(10k) in NaCl solution was then added to the final concentrations of 0.003 
mM. EDC/NHS crosslinker (0.006 mM/0.006 mM) was used as positive control. The 
solutions were incubated for 1 h at 37 ºC to complete gelatin crosslinking reaction. 
After that, the crosslinked hydrogel was further treated with 0.1 M glycine NaCl 
solution to block non-reacted aldehyde groups and washed three times with 
double-distilled water [29]. The measurement of crosslinking degree of gelatin 
hydrogel was determined by TNBS assay as previously described [30]. Briefly, the 
hydrogel containing approximately 15 mg gelatin was placed in a 15-mL screw cap test 
tube. 1 mL NaHCO3 solution (pH 8.5, 4%) and 1 mL TNBS solution (0.5%) were 
added to the tubes and the mixtures were held at 40 ºC for 4 h and 3 mL HCl solution (6 
g/L) was added to change the pH value and the reaction mixture was autoclaved at 120 
ºC and 15-17 psi for 1 h. The trinitrophenyl (TNP)-ε-amino derivative is stable under 
these conditions [31]. The obtained solution was then diluted with 5.0 mL ddH2O and 
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extracted with 20 mL diethyl ether three times to remove excess unreacted TNBS and 
TNP-α-amino groups. Ether was removed by heating the solution to 40 ºC for 15 min in 
a water bath and the aliquot was diluted with 30 mL ddH2O and the absorbance was 
recorded at 346 nm in a Shimadzu UV-2450 spectrophotometer. The sample was read 
against reagent blank. The blank was prepared using the same method as the sample. In 
the blank preparation, HCl solution was added before the addition of TNBS solution to 
prohibit TNBS reacting with primary amino groups of gelatin. The crosslinking degree 
could be obtained from the differences between the absorbance values before and after 
crosslinking [32]. The crosslinking degree was defined by Eq. (5.1): 
Crosslinking degree ሺ%ሻ ൌ ሺ1 െ Aୠୱ୭୰ୠୟ୬ୡୣ ୭୤ ୡ୰୭ୱୱ୪୧୬୩ୣୢ ୦୷ୢ୰୭୥ୣ୪Aୠୱ୭୰ୠୟ୬ୡୣ ୭୤ ୬୭୬ିୡ୰୭ୱୱ୪୧୬୩ୣୢ ୦୷ୢ୰୭୥ୣ୪ሻ ൈ 100     (5.1) 
5.2.3.2 Oscillatory Rheology Measurements 
In order to identify the gelling time of the mirogel, rheological measurements 
were performed at 37 ºC using a Rheostress RS600 (Haake Thermo Electron 
Corporation GmbH, Karlsruhe, Germany) with parallel plate geometry (20 mm 
diameter) at a gap of 1 to 2 mm as described before [33]. Briefly, the mixed solution 
was added to the plate at 37 ºC after different crosslinkers was dissolved in 
alginate/gelatin mixed solution. The test methods employed were oscillatory time and 
stress sweep at 37 ºC. Time sweep experiments were carried out to determine the 
storage (G´) and loss (G") moduli at 37 ºC. The measurements of the G´ and G" moduli 
during the gelation were recorded as a function of time at a constant stress of 1 Pa for 
different crosslinkers. As soon as the mixed solution was introduced onto the plate, the 
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data were collected at 4 min. The gel point was defined as the time when G´ was equal 
to G" [34]. The impact of different crosslinkers on G´ and G" was investigated. 
EDC/NHS crosslinker was used as a control. After the mixed solution containing 
crosslinker was loaded onto the rheometer at 37 ºC for 1 h, stress sweep experiments 
were performed to provide G´ and G" moduli to determine the linear viscoelastic region 
at a constant frequency of 1 Hz.  
5.2.4 Swelling of Microgels at Stage 2 
The swelling degrees of microgels with or without chemical crosslinking were 
measured using a method earlier described [26, 35]. The microgels (lyophilized weight: 
around 5 mg) at stage 2 were collected by centrifuge and immersed in 0.5 mL distilled 
water for 24 h. No obvious weight increase was observed after 24 h. Swollen microgels 
reached the swelling equilibrium. These swollen microgels were collected by 
centrifugation, gently wiped with filter paper to remove the water on the surface, and 
placed in a vial of known weight (Wv). The weight of swollen microgels and vial was 
recorded (Ws,v). The amount of water which was trapped in the gaps of microgels is 
very little and negligible. The weight of lyophilized microgels and vial was recorded 
(Wl,v). The swelling degree was then calculated based on Eq. (5.2), 
S ൌ W౩,౬ିW౬Wౢ,౬ିW౬                                                (5.2) 
5.2.5 Mechanical Stability Test of Microgels 
The mechanical stability of microgels was evaluated by agitation of 0.5 mg 
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lyophilized microgels in a plastic vial together with 0.7 mL PBS buffer on a vortex 
mixer at about 1800 rpm. Two polystyrene particles (diameter: 0.5 mm) were added to 
increase the force to break the microgels. At various time intervals, the vial was 
removed from the mixer and 0.1 mL was extracted for counting the number of 
remaining microgels under phase-contrast microscope. The vial was placed back on the 
vortex mixer and continued for agitation. Three independent experiments were 
performed for each microgel. 
5.2.6 Encapsulation of 3T3 Cells, Cell Culture, and Cell Viability Assay 
Cell pellet was suspended in the mixed solution of sodium alginate (2.5%, w/v) 
and gelatin (3%, w/v). After the crosslinker was added, the final cell density was 2×105 
cells/mL. Cell encapsulation was conducted according to the microgel preparation 
method described above. The encapsulated 3T3 cells were cultivated in DMEM 
containing 10% FBS and 1% PS for 12 days. Viability of the encapsulated 3T3 cells 
was assessed by LIVE/DEAD reduced biohazard cell viability kit. Briefly, non-viable 
cells were stained red and viable cells were stained green at predetermined time points. 
Cell viability was assessed by counting the number of green cells over the total number 
of cells and expressed as a percentage (n=50 microgels). Samples were analyzed under 
a fluorescence microscope (Olympus IX71, Olympus Optical Co. Ltd, Tokyo, Japan). 
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5.3 Results and Discussion 
5.3.1 Characterization of Microgels 
The formulations of microgels were tabulated in Table 5.1. Sodium alginate 
solution or mixed solution of sodium alginate and gelatin containing crosslinker or 
sPEG-4A(10k) was sprayed into CaCl2 solution to produce microgels at stage 1. After 
held for 1 h at 37 ºC, the microgels at stage 2 were recovered by centrifuge and rinsed 
in NaCl solution. The microgels were found to be stable in NaCl solution after microgel 
recovery (Figure 5.1a), and exhibited negative surface charge (Figure 5.2). So the 
microgel surface could be used for polyelectrolyte Layer-by-Layer self-assembly to 
generate protective membrane for use in biomedical application [36]. 
Table 5.1. Size measurement of microgels 
 
 
Figure 5.1. Optical images of (a) microgel-4(S2) and (b) microgel-4(S5). (Scale bar:100 µm) 




Microgel-1 Sodium alginate (2.5%, w/v) 55 86.6
Microgel-2 Sodium alginate (2.5%, w/v) + Gelatin (3%, 
w/v) +EDC (0.006 M)/NHS (0.006 M)
98.5 123.5 
Microgel-3 Sodium alginate (2.5%, w/v) + Gelatin (3%, 
w/v) + sPEG-4A(10 k) (0.003 M)
87.7 109.4 
Microgel-4 Sodium alginate (2.5%, w/v) + Gelatin (3%, 
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The microgels at stage 2 were immersed in chitosan solution (MW<10000) 
and rinsed three times in NaCl solution to produce the microgels at stage 3. Alginate 
coating was then added by incubating the microgels at stage 3 in sodium alginate 
solution to bind positively charged chitosan on the microgel surface and the microgels 
at stage 4 were washed with NaCl solution. The microgels at stage 5 were formed 
after citrate treatment. Phase-contrast microscope was used to image the microgels. 
The representative microscopic images of microgels were shown in Figure 5.1. It can 
be observed that spherical microgels were intact with smooth surface. At least 100 
microgels were randomly selected for size measurement using software ImageJ, 
which provided diameters of microgels. It was found that the diameters of the 
microgels were relative uniform around 100 µm. Figure 5.3 shows the diameters of 
microgels at different preparation stages of microgel-4. 
 
Figure 5.2. Zeta potential measurements for chitosan coating, alginate coating, and citrate 
treatment. Data are shown as mean ± SD (n=3). 
 




Figure 5.3. Sizes of microgels at different preparation stages. Data are shown as mean ± SD 
(n=3). 
The self-assembly of chitosan and alginate layers was monitored by Zetasizer 
(Nano ZS, Malvern). Chitosan and alginate were deposited on the surface of microgels, 
and the zeta potentials of the microgels were observed to change from about -30 mV 
before chitosan coating to about +15 mV after chitosan coating (Figure 5.2), which 
indicates the formation of the desired layer. This result indicates that the microgel cores 
had enough negative surface charge after gelation. The surface charge made chitosan 
and alginate deposition onto microgels straightforward. The polyelectrolyte layer may 
provide a protective membrane for encapsulated biomolecules and cells and stabilize 
microgels against dissolution in a biological environment. 
5.3.2 Measurement of Crosslinking Degree 
sPEG-4A-GS(10k) molecule is a pegylated structure presenting four terminal 
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NHS reactive groups. NHS terminal groups react with the amine groups of gelatin 
inducing crosslinking (Scheme 5.2). TNBS reacts with primary amines of gelatin rather 
than the hydroxyl groups or the imidazole nitrogens and the resulting TNP-S-derivative 
is labile while TNBS reacted with sulfhydryl groups [37]. TNP-α-amino groups can be 
removed from the aqueous phase through the ether extraction. The specific 
determination of ε-amino groups was allowed after the removal of TNP-α-amino 
groups. The duration of the TNBS reaction time was required for the completion of the 
TNBS reaction with crosslinked and poorly soluble gelatin. Water-soluble 
sPEG-4A-GS(10k) and EDC/NHS crosslinker have been used as crosslinking agents in 
biomedical application [38]. Considering the crosslinking mechanism by EDC/NHS, 
alginate could be also crosslinked since carboxyl groups rich in alginate could attack 
EDC. The crosslinking efficiency is not affected when the crosslinker 
sPEG-4A-GS(10k) was applied. The degrees of crosslinking are tabulated in Table 5.2. 
The crosslinking efficiency of EDC/NHS was higher than that of sPEG-4A-GS(10k), 
while the molar ratio of sPEG-4A-GS(10k) to EDC was 1:2. It may be due to the fact 
that some of functional groups of sPEG-4A-GS(10k) were less active in the reaction. 
Table 5.2. Crosslinking degree and gelling time 
 
Samples Crosslinking degree Gelling time (min) 
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5.3.3 Rheological Analysis of Gelatin/Alginate Hydrogel 
The measurements of rheological properties are very useful to characterize the 
sol-gel transition [39-41]. Dynamic rheometry is a tool which allows properties to be 
probed without disruption of the microstructure [34]. It is also a method for studying 
the viscoelastic material functions, such as dynamic shear moduli G´ and G". The two 
viscoelastic material functions were defined by Eq. (5.3) and Eq. (5.4): 
G´ ൌ σ଴ cosሺδሻ /γ଴                                                 (5.3)  
G" ൌ σ଴sin ሺδሻ/γ଴                                                 (5.4) 
Where σ0 is the stress, γ0 is the strain amplitude and δ is the phase angle between 
stress and strain. G´ is storage modulus which measures the elastic energy representing 
the elastic portion and G" is loss modulus which measures the dissipated energy 
representing the viscous portion [42]. The relative magnitudes of G´ and G" will 
provide information regarding the proportion of the stored energy and dissipated energy 
during the flow over each cycle of frequency oscillation that indicates the overall 
viscoelasticity of the sample.  
Attention has been focused on the gel point determination in polymer 
crosslinking systems. Sol-gel transition of polymer gels can be monitored from the 
development of the viscoelastic functions of the material at the gel point which can be 
characterized by the appearance of one macromolecule chain with infinite molecular 
weight in an reactive system [43]. It can be determined by the viscoelastic properties 
change abruptly from an liquid-like state to a solid-like state [44]. The gel point 
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coincides with the point at which G´ equals to G". 
To improve knowledge regarding the gelation kinetics and properties of 
microgels in reactive system, the rheology properties of gelatin/alginate hydrogels 
were studied. Storage modulus G´ and loss modulus G" were monitored. Figure 5.4 
shows the time sweep profiles of G´ and G" moduli for alginate/gelatin solution versus 
crosslinking time. The rheological test was started 4 min after the crosslinker was added 
to the mixed solution of gelatin and alginate. At the beginning, G" was larger than G´, 
which indicated the sample was still in a liquid state and viscous properties dominated. 
The liquid-like state began to turn into a gel-like state because of the formation of the 
crosslinked network near the gel point. The elastic properties began to dominate the 
viscous properties after a G´ and G" crossover. The time required for G´ and G" to 
increase to the crossover was the gelling time. From Figure 5.4, it was obviously 
observed that EDC/NHS crosslinker led to gelling time of 4.9 min while the gelling 
time of hydrogel crosslinked by sPEG-4A-GS(10k) was 36 min, indicating high 
reactive activity of EDC/NHS crosslinker. Experiments were carried out in triplicate. 
Gelling time of the precursors plays a key role in the design of our microgels. Short 
gelling time can lead to big and non-circular microgels with the droplet generation 
method. Thus, sPEG-4A-GS(10k) can be used in optimally designing the microgel with 
respect to the gelling time.  
 





Figure 5.4. Gel point measurement. Storage modulus and loss modulus of the crosslinked 
hydrogels with (a) sPEG-4A-GS(10k) and (b) EDC/NHS as a function of time. 
The stress range over which G´ and G" are independent of the applied shear 
stress is the linear viscoelastic region [34]. The linear viscoelastic region profiles of 
crosslinked hydrogel were shown in Figure 5.5. G´ and G" were quite independent of 
stress in the linear viscoelastic region. G´ values were always larger than G" values over 
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the shear stress range from 1 to 1000 Pa, which confirmed their gel states. As shown in 
Figure 5.5, an oscillatory stress sweep measurement shows that the hydrogel 
crosslinked by EDC/NHS within its linear viscoelastic range up to almost 1000 Pa in 
terms of shear stress had G´ dominating over G´ of the hydrogel crosslinked by 
sPEG-4A-GS(10k). G´ represents the elastic portion in viscoelastic hydrogel which is 
correlated with the crosslinking degree in the hydrogel network. The high G´ values of 
the hydrogel were due to its high crosslinking degree (Table 5.2). The hydrogel 
crosslinked by EDC/NHS had high G´ values, which indicates it was much stiffer [40]. 
Observed from Figure 5.5, the hydrogel crosslinked by EDC/NHS had the lower ratio 
of G" to G´ than the hydrogel crosslinked by sPEG-4A-GS(10k), which means that the 
former is more solid-like than the latter, indicating predominant elastic behavior. The 
more solid-like property can be attributed to the higher crosslinking degree in the 
hydrogel crosslinked by EDC/NHS, as proven by TNBS assay. In addition, 
incorporating ‘zero length’ amide crosslinks can also make the hydrogel stiffer than the 
incorporation of sPEG-4A-GS(10k) crosslinker with soft PEG segment.  
The stress generated by cellular growth in the hydrogel with more solid-like 
property may cause some biological limitations including long-term stability and 
reduced cell growth in the application of cell encapsulation [45-47]. Thus, it is expected 
that hydrogel crosslinked by sPEG-4A-GS(10k) is more suitable for cell delivery. 
 




Figure 5.5. Storage modulus and loss modulus of the cross-linked hydrogels with different 
crosslinkers ( : G’ of hydrogel crosslinked by sPEG-4A-GS(10k), : G” of hydrogel 
crosslinked by sPEG-4A-GS(10k), : G’ of hydrogel crosslinked by EDC/NHS, : G” of 
hydrogel crosslinked by EDC/NHS).   
5.3.4 Swelling Properties of Microgels 
Microgel swelling experiments revealed a significant difference in swelling 
degrees of different microgels. Swelling degree is a reflection of the crosslinking 
degree in hydrogel system. In principle, the polymer gel becomes more compact when 
the crosslinking degree increases, leading to a decrease of microgel swelling degree. 
Crosslinking resulted in low swelling degree of gelatin-alginate microgels [35]. In the 
preparation of the microgels, different crosslinkers are influencing the properties of 
microgels. We investigated the dependence of swelling degrees on different 
crosslinkers. Figure 5.6 presents the swelling degree of the microgels with or without 
chemical crosslinking. As shown in Figure 5.6, the swelling degree of microgel-4(S2) 
crosslinked by sPEG-4A-GS(10k) was higher than it of microgel-2(S2) crosslinked by 
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EDC/NHS crosslinker. In hydrogel system, swelling degree reflects the crosslinking 
degree of hydrogel [48]. In principle, high crosslinking degree results in more compact 
polymer gel networks [49]. The change of swelling degree caused by the crosslinking 
degree can affect cell viability through changing water content of a hydrogel. Hydrogel 
porosity can be reflected by the water content of a hydrogel [50, 51]. High porosity of 
microgel is beneficial to cell culture [52]. The expected result is that an acceptable 
environment containing high water content could sustain cell viability inside the 
hydrogel matrix. In this work, the swelling degree of microgel-3(S2) was significantly 
greater than the other two crosslinked microgels. However, the low mechanical stability 
of uncrosslinked microgel limits its application in cell delivery. 
 
Figure 5.6. Swelling degrees (w/w) of microgels prepared in air-driven droplet generating 
method. Data are shown as mean ± SD (n=3). 
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5.3.5 Mechanical Stability of Microgels 
The mechanical stability of the microgels was evaluated by agitation of 
microgels on a vortex mixer. Figure 5.7 shows the relative numbers of remaining 
microgels as a function of time. At 33 h, the remaining microgel-2(S5) and 
microgel-4(S5) were around 80% while the other remaining microgels were around 
20%. At different intervals, more microgels without chemical crosslinking were 
fractured compared to chemically crosslinked microgels. It was observed that 
chemically crosslinked microgels were more difficult to deform. The microgel-3(S5) 
had the higher mechanical strength than microgel-1(S5), which may be due to 
unreleased gelatin and PEG enhancing its mechanical stability. The results indicate that 
the chemical crosslinking was efficient to strengthen the cores of the microgels. Thus, 
crosslinked microgels would be of great potential for cell delivery. 
 
Figure 5.7. Percentage of remaining microgels with and without chemical crosslinking as a 
function of vortexing time at 1800 rpm. Data are shown as mean ± SD (n=3). 
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5.3.6 Encapsulation of Cells within Microgels 
To validate the application of the cell-encapsulated microgels in the biomedical 
applications, 3T3 fibroblast cells were encapsulated within the microgels and the 
viability of cells was assessed by using a viability assay. Microgels for cell delivery 
were generated based on the conditions obtained from ‘Preparation of Microgels’ 
section. 3T3 cells were collected after trypsinization and resuspended in the mixed 
solution at a concentration of 2×105 cells/mL. The solution containing 3T3 cells was 
dropped into calcium chloride solution to produce microgels. The microgels were 
found to be stable in NaCl solution after the removal of CaCl2 solution and exhibited 
negative surface charge. So the microgels could be used as the microgel cores for 
polyelectrolyte to form protective membranes on the cores. All microgels were coated 
with chitosan and alginate. After citrate treatment, the microgels encapsulating cells 
were formed. Figure 5.8 shows the representative microscopic image of Microgel-4(S5) 
encapsulating 3T3 cells.  
 
Figure 5.8. Light micrographs of microgels containing 3T3 cells (0 day). Cells were 
encapsulated by microgel-4(S5). (Scale bar: 100 µm). 
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Cell viability was characterized by LIVE/DEAD reduced biohazard cell 
viability kit. Microgels encapsulating cells were collected at predetermined intervals. 
The encapsulated cells were stained with LIVE/DEAD reduced biohazard cell viability 
kit (Figure 5.9) and analyzed for cell viability. To learn about the influence of microgel 
fabrication process on the cell viability, cell viability at stage 5 was checked. The 
viability of the cells was not qualitatively different after preparation stages. It is 
observed that cell viability was remained above 80% (Figure 5.10). The result indicates 
cell-friendly feature of the cell encapsulation method. The preparation stages did not 
result in a significant amount of cell death, similar to previously published studies [47]. 
 
Figure 5.9. Fluorenscent micrographs of cell-containing microgel-4(S5) stained with 
LIVE/DEAD stains at 0 day. (Scale bar: 100 µm) 
Most of the cells were encapsulated in the core of the microgel. In the 
long-term (>2 days) cell viability tests, the 3T3 cells in microgel-4(S5) were viable 
for at least 9 days in in vitro culture. 3T3 cells cultured in microgel-1(S5) for 12 days 
served as the control. Cell culture in the microgels like microgel-1(S5) is accepted as 
a method for successfully encapsulating Human osteoblast-like cells [47], Human 
embryonic stem cells [53] and so on. Clumps of cells, as well as individual cells, were 
observed in microgel-4(S5) similar to microgel-1(S5). In this work, some of the 
Cell Microgel
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microgel-1(S5) were broken at 5 day and cells were released, which is due to the low 
mechanical stability of liquid-core microgel-1(S5) [47]. At 12 day, most of released 
cells from microgel-1(S5) adhered to the bottom of 24-well culture plates and 
proliferated. Chemical crosslinkers, such as EDC/NHS and GTA, were commonly 
used for stabilization. However, they were not allowed in injectable hydrogel [54]. 
From the cytotoxicity result, no cytotoxicity of sPEG-4A-GS(10k) was observed with 
cell viability over 80% compared to the crosslinker EDC/NHS at 2 day. The 
comparison of sPEG-4A-GS(10k) and GTA has been shown in the literature [33]. The 
crosslinker sPEG-4A-GS(10k) is more suitable than GTA in the application of 
injectable hydrogel. sPEG-4A(10k) was used as a control to study the influence of 
crosslinking on cell viability. There is no significant difference between 
microgel-3(S5) and microgel-4(S5). Therefore, the gelatin-based microgel would be a 
suitable cell carrier for cell delivery.  
 
Figure 5.10. Cell viability measured using a LIVE/DEAD reduced biohazard cell viability kit. 
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5.4 Conclusions  
A gelatin-based microgel with soft chemically crosslinked gelatin core and 
permeable chitosan/alginate membrane has been successfully prepared by using an 
easy method, which includes the processes of air-driven droplet generating in the 
presence of calcium chloride, chemical crosslinking of gelatin, coating of 
chitosan/alginate and removing of alginate template from the microgel core. 
sPEG-4A-GS(10k) was used to chemically crosslink gelatin-based microgel for cell 
delivery because of its low reaction activity, non-cytotoxicity and soft segments in 
PEG backbone. Mechanical stability of the microgels was enhanced through chemical 
crosslinking. 3T3 cells have been successfully encapsulated into the gelatin-based 
microgels. The 3T3 cells maintained their viability (over 80%) for 9 days in the 
microgels. Therefore, the gelatin-based microgel would be a promising candidate as 
cell carrier for cell delivery.   
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CHAPTER 6 CONCLUSIONS AND FUTURE RESEARCH 
6.1 Summary of Results 
This work presented in the thesis revolves around a study of the synthesis and 
preparation of biomaterials based on gelatin to investigate their delivery applications.  
In the first part of this work, a thermosensitive and biodegradable graft 
copolymer PNIPAAm-grafted gelatin and a diblock copolymer MPEG-PDMAEMA 
are synthesized by activators regenerated by electron transfer (ARGET) atom transfer 
radical polymerization (ATRP). The chemical structures and molecular characteristics 
of PNIPAAm-grafted gelatin and MPEG-PDMAEMA are confirmed by 1H NMR 
spectroscopy and GPC. The thermosensitivity of PNIPAAm-grafted gelatin is studied 
by 1H NMR and TEM. The core-shell-corona micellar complex is obtained after the 
addition of cationic MPEG-PDMAEMA onto the micelles formed by 
PNIPAAm-grafted gelatin. The size of micellar complex ranging from 105.3 to 134.4 
nm is controlled by the length of PNIPAAm segment. The structure of micellar 
complex is confirmed by TEM. The degradation and stability analysis of the micellar 
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complex indicate that the block copolymer MPEG-PDMAEMA efficiently protects 
the core of the micellar complex because degradable gelatin and negative charged 
surface of micelles are efficiently screened by PEG. The thermosensitive and 
sustained release of MTX is obtained. Confocal laser scanning microscopy reveals a 
clear distribution of micellar complexes after cellular uptake. The cell viability assay 
shows that all synthesized copolymers did not elicit cytotoxic response against the 
L929 cells with the copolymer concentration up to 15.6 mg mL-1. The study 
presenting a new thermosensitive micellar complex suggests possibilities in designing 
each component to obtain multifunctionality of micellar complex.  
In the second part of this work, we demonstrate a simple and practical method 
to prepare chemically crosslinked gelatin-based hydrogels using β-CD as the 
crosslinking agent as well as host molecule for enhanced binding of anticancer drug 
MTX, to achieve relatively high drug loading level as well as controlled and sustained 
release of the anticancer drug. For this purpose, a series of new β-CD-crosslinked 
gelatin-based hydrogels (β-CD-Gel-1, β-CD-Gel-2, and β-CD-Gel-3), and a 
dextran-crosslinked gelatin-based hydrogel (Dex-Gel) as control compound, were 
synthesized and characterized. For β-CD-Gel-1, β-CD-Gel-2, and β-CD-Gel-3, the 
β-CD content was 11.1, 13.5, and 15.2%, and the crosslinking degree was 21.3, 24.3, 
and 36.5%, respectively, while the crosslinking degree was 26.4% for Dex-Gel. The 
four gelatin-based hydrogels could swell in PBS buffer up to 200 – 900%. The 
hydrogels degraded hydrolytically and the degradation was accelerated by collagenase 
in PBS buffer. It was found that the higher water content resulted in faster 
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biodegradation of the hydrogels regardless of their crosslinker used. Pyrene was used as 
a fluorescence probe to investigate the micro-environment of the gelatin-based 
hydrogels. Pyrene was well adsorbed in the -CD-crosslinked hydrogels, and the 
pyrene molecules in the hydrogels were included and complexed within the 
hydrophobic cavities of the β-CD crosslinkers. In contrast, Dex-Gel only adsorbed 
trace of pyrene. The anticancer drug MTX was used as a model drug, and the adsorption, 
loading, binding and complexation, and release of MTX in or from the hydrogels were 
investigated. MTX was adsorbed and loaded into the hydrogels by immersing the 
swollen hydrogel samples in MTX saturated aqueous solution. The loading of MTX in 
the hydrogels was confirmed by measuring the UV-vis spectra of the MTX-loaded 
hydrogels, the spectra indicated that the loaded MTX was complexed by β-CD in the 
β-CD-crosslinked hydrogels. The loading level was 7.8, 12.2, 14.9, and 16.4 mg/g for 
Dex-Gel, β-CD-Gel-1, β-CD-Gel-2, and β-CD-Gel-3, respectively. The complexation 
of MTX with β-CD crosslinkers largely increased the loading level of MTX in the 
hydrogels. The complexation could also reduce the initial burst release effect, and then 
retard the release of the complexed MTX for a certain period, until the hydrogels started 
to hydrolytically degrade and all remained MTX was released. The above mentioned 
effects were particularly prominent for β-CD-Gel-3 that had highest β-CD content. Due 
to the unique structures and properties of the β-CD-crosslinked gelatin-based hydrogels, 
the hydrogels demonstrated an interesting multiphasic profile for controlled and 
sustained release of MTX drug. Thus, the β-CD-crosslinked gelatin-based hydrogels 
may be utilized as a promising drug carrier for controlled and localized delivery of 
 




In the third part of the work, a gelatin-based microgel was prepared by a 
simple method starting from gelatin and alginate. The microgel was composed of a 
soft gelatin-based core coated by a permeable membrane. Gelatin-based core was 
moderately crosslinked by a novel crosslinker sPEG-4A-GS(10k). sPEG-4A-GS(10k) 
was chosen to crosslink gelatin-based microgel for cell delivery because of its 
moderate crosslinking ability towards protein, non-cytotoxicity and soft segments. 
Microgels with diameters around 100 µm and narrow size distribution were achieved 
and the surface zeta potential change of the microgel indicated the formation of 
chitosan and alginate layers outside the gelatin core. The micrographs of microgels 
indicated that the microgels were of smooth surface and uniform size. The rheological 
properties and crosslinking degree of gelatin/alginate hydrogel with the same 
composition as microgel were investigated to gain insight into the properties of 
crosslinked microgels. By comparison with the commonly used crosslinking system 
EDC/NHS, the use of sPEG-4A-GS(10k) as crosslinker could lead to moderate 
crosslinking degree, appropriate gelling time, sufficient mechanical strength, and less 
solid stress induced by cell growth in the crosslinked microgel. The resultant 
crosslinked microgels were able to hold more water than the microgels crosslinked by 
EDC/NHS. The mechanical stability of the microgels was enhanced greatly upon 
chemical crosslinking by sPEG-4A-GS(10k). 3T3 cells were successfully 
encapsulated into gelatin-based microgels, where the 3T3 cells maintained their 
viability (over 80%) for 9 days.  
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6.2 Possible Future Research 
As pointed out in the Chapter 3, a new micellar complex was designed. 
Further research should be carried out to obtain the multifunctionality of the micellar 
complex. For example, it is a potential gene carrier because of the formation of the 
MPEG-PDMAEMA/DNA complex. Gene therapies by nonviral vectors could exhibit 
the potential to cure cancer effectively, although the transfection efficiency is 
unfavorable. A novel therapy strategy combining chemical and gene therapies has 
attracted much attention [1, 2]. As nonviral gene vectors, hydrophobically modified 
cationic polymers can be used as the carriers to deliver anticancer drugs 
simultaneously. The synergistic/combined effect of drug and gene will enhance the 
antitumor effect in cancer therapy. In this work, it is expected that the hydrophobic 
core can be used as a drug carrier and PDMAEMA shell can form complex with DNA. 
Further research will be conducted by condensing negatively charged DNA into 
micellar complex.  
In the study of gelatin-based hydrogel, β-CD has been used as crosslinking 
agent in previous work. CD is one of the most widely used supramolecular building 
blocks for a wide range of biomedical applications [3]. The most common CDs are a 
series of natural cyclic oligosaccharides composed of 6, 7, or 8 D(+)-glucose units 
linked by α-1,4-linkages, and named α-, β-, γ-CD, respectively [4]. Inclusion complex 
is formed between CDs and sized molecules [5]. Besides β-CD, further research could 
be conducted by using α-CD and γ-CD with different sizes and solubilities. For 
example, γ-CD can be used as the crosslinker in spite of β-CD. The large cavity of 
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γ-CD can form inclusion complex with different drugs.  
In the construction of gelatin-based microgels, it has been demonstrated that 
the microgel has a potential application in cell delivery. This research focused on the 
design of the microgels and microencapsulation of cells (e.g. 3T3). In cell therapy 
application, therapeutic proteins are released by the cells encapsulated by microgels 
over prolonged periods [6]. The cells should survive over prolonged periods in 
non-dividing state. Bioengineered cells and stem cells have been considered 
therapeutic for the treatment of many diseases including those with deficient hormone 
production. For example, retinal pigment epithelial (RPE) cells do not divide and 
provide dual benefits in Parkinson’s disease by producing both dopamine and 
neurotrophic support of the basal ganglia [7]. This work suggests further study as to 
whether there is any effect of the microgels on the functionality of the encapsulated 
cells which can secret therapeutic protein. Furthermore, it may be of great interest to 
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